CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0554
(Tag F0554)
Could have caused harm · This affected 1 resident
Based on observation, staff interview, and clinical record review, the facility failed to evaluate for self administration of medications for one of 21 residents, Resident #8.
The Findings Include:
D...
Read full inspector narrative →
Based on observation, staff interview, and clinical record review, the facility failed to evaluate for self administration of medications for one of 21 residents, Resident #8.
The Findings Include:
Diagnoses for Resident #8 included; Pneumonia, sepsis, chronic kidney disease, and major depression. The most current MDS (minimum data set) was a quarterly assessment with an ARD (assessment reference date) of 1/29/22. Resident #8 was assessed with a cognitive score of 11 indicating moderately cognitively intact.
On 4/19/22 at 10:56 a.m., while interviewing Resident #8 medications were observed on the bedside table in a dispense cup. Resident #8 verbalized not wanting to take the medications until after breakfast so had asked the nurse to leave them on the table.
On 4/19/22 at 11: 06 a.m., licensed practical nurse (LPN #4) was interviewed and stated she had brought the medications in to Resident #8 earlier and Resident #8 said to leave them and would take them after breakfast. When asked about concerns of leaving medications at the bedside, LPN #4 stated understanding that medications should not be left at bedside. LPN #4 also was uncertain if Resident #8 was evaluated to self administer medications.
On 4/20/22 Resident #8's medical records were reviewed and did not evidence that an assessment or a care plan for self administration had been completed.
On 04/20/22 at 5:32 p.m., the above information was presented to the administrator and director of nursing (DON) and they were asked to present any additional information.
On 4/20/22 the DON presented a policy titled Self Administration of Medication and Treatments and read in part: 1. As part of their overall evaluation, the staff and practitioner will assess each resident's mental and physical abilities and choice to determine whether self-administering medications and/or treatments is clinically appropriate for the resident.
No other information was presented prior to exit conference on 4/21/22.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Transfer Requirements
(Tag F0622)
Could have caused harm · This affected 1 resident
Based on staff interview, and clinical record review, the facility failed to document a discharge to the hospital in the clinical record for one of 21 residents, Resident #12.
The Findings Include:
R...
Read full inspector narrative →
Based on staff interview, and clinical record review, the facility failed to document a discharge to the hospital in the clinical record for one of 21 residents, Resident #12.
The Findings Include:
Resident #12 was admitted with diagnosis that included: Dementia, Hypotension, dysphagia, peripheral vascular disease, and depression. The most current MDS (minimum data set) was a quarterly assessment with an ARD (assessment reference date) of 2/25/22. Resident #12 was assessed with a cognitive score of 10 indicating moderately cognitively intact.
On 4/19/22 Resident #12's medical record was reviewed. The MDS list indicated Resident #12 had been discharged to the hospital on 3/15/22.
Review of the progress notes dated 3/15/22 indicated Resident #12 was found in bed with . medium amount of coffee ground emesis
A nursing note dated 3/16/22 documented, Resident returned from the hospital
There were no other progress notes or discharge notes indicating why Resident #12 had gone to the hospital.
On 04/20/22 at 10:19 a.m. registered nurse (RN #2) reviewed Resident #12's medical record and could not find any documentation regarding the discharge to the hospital. RN #2 stated there should be a progress note or a transfer assessment when a resident goes out to the hospital.
On 04/20/22 at 5:32 p.m. the above information was presented to the DON (director of nursing) and administrator.
No other information was presented prior to exit conference on 4/21/22.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0635
(Tag F0635)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, staff interview, clinical record review and facility document review, the facility staff failed to ensure ...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, staff interview, clinical record review and facility document review, the facility staff failed to ensure admission orders for the immediate care and services of a central line catheter for one of 21 residents in the survey sample, Resident #230.
Findings include:
Resident #230 was admitted with diagnoses that included, but were not limited to: BPH (benign prostatic hypertrophy) with urinary retention, indwelling Foley catheter, urinary tract infection, entercolitis, C-Diff (clostridium difficile) infection, PVD (peripheral vascular disease), dementia, high blood pressure and bacteremia (infection in the blood).
The resident's admission MDS (minimum data set) was still in progress. Resident #230's nursing admission assessment dated [DATE] documented, that the resident had dementia with cognitive deficits (unable to answer to place, time and situation). This admission assessment did not include the presence of a central line for Resident #230.
Resident #230's hospital Discharge summary dated [DATE] documented the resident grew bacteria in the blood and urine and would receive IV Vancomycin for a total of 14 days (7 days remaining when admitted to the long term care facility), a [NAME] (central line access) catheter device was placed at the hospital for the use long term antibiotic administration.
On 04/20/22 at 11:36 AM, Resident #230 was observed in his room. An IV (intravenous) pole with machine was observed in the corner of the room. Resident #230 was asked if he had any type of IV access. Resident #230 started feeling around on his body and under the blankets. The resident was asked again if he had IV access and was asked if there was something in/on his chest area. Resident #230 then started pulling at his shirt. The resident was asked to pull the collar of his shirt down in order to observe. The resident pulled down from his neck, exposing a central line catheter in the right chest wall. The central line catheter had a clear, dry dressing intact dated 04/15/22.
The physician's orders were then reviewed. There were no care orders for the central line access device (dressing changes, IV flush, etc.).
The MARs/TARs (medication/treatment administration records) were reviewed. There were no care orders listed for the central line catheter.
The current care plan documented, .resident will not have complications related to infection .meds/treatments as ordered .IV medications related to C-diff, UTI .
On 04/20/22 at 4:45 PM, LPN (Licensed Practical Nurse) #1 was interviewed regarding Resident #230's central line access. LPN #1 was asked about what to do for Resident #230's central line. LPN #1 stated, Nothing. LPN #1 was asked why and the LPN stated, We have no orders. LPN #1 was then asked why there were no orders for the resident's central line access device. LPN #1 stated, That's a good question.
At 4:50 PM, the unit manager, registered nurse (RN) #1, was interviewed regarding Resident #230's orders for the care of the central line. RN #1 stated that she had not personally done any dressing changes or care for the resident's central line access. RN #1 stated that the central line access is supposed to be flushed and have dressing changes. RN #1 was asked where that information comes from. RN #1 stated, Physician's orders. RN #1 was made aware that there were no physician orders for the care of the central access line and was asked why there weren't any orders. RN #1 stated, I did not put them in. RN #1 began to look in the computer system and stated, No orders for flushes, or dressing changes .Nope, there aren't any in there. RN #1 was asked how nursing would know how to flush or when to change the dressing. RN #1 stated, From our provider. RN #1 was asked if they have standing orders for central line access device care and maintenance. RN #1 stated, No ma'am, no standing orders.
On 04/20/22 at 5:15 PM, the DON (director of nursing), ADON (assistant director of nursing) and the administrator were made aware of concerns regarding Resident #230 not having any care orders for central line access device. A policy was requested on admission orders, specifically central line access device care on admission.
A policy was presented titled, Medication Orders. The policy documented, .Each resident must be under the care of a Licensed Physician .a current list of orders must be maintained in the clinical record of each resident .All orders must clearly identify the resident for whom the order is intended .
A policy was presented titled, Central Venous Catheter documented, .To provide a general procedure regarding central venous catheters .Obtain physician's order .
No further information and/or documentation was presented prior to the exit conference on 04/21/22.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0655
(Tag F0655)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, staff interview and clinical record review the facility staff failed to ensure a baseline care plan for a ...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, staff interview and clinical record review the facility staff failed to ensure a baseline care plan for a central venous access catheter was completed for one of 21 residents in the survey sample, Resident #230.
Findings include:
Resident #230 was admitted with diagnoses that included, but were not limited to: BPH (benign prostatic hypertrophy) with urinary retention, indwelling Foley catheter, urinary tract infection, entercolitis, C-Diff (clostridium difficile) infection, PVD (peripheral vascular disease), dementia, high blood pressure and bacteremia (infection in the blood).
The resident's admission MDS (minimum data set) was still in progress. Resident #230's nursing admission assessment dated [DATE] documented, that the resident had dementia with cognitive deficits (unable to answer to place, time and situation). This admission assessment did not include the presence of a central line for Resident #230.
Resident #230's hospital Discharge summary dated [DATE] documented the resident grew bacteria in the blood and urine and would receive IV Vancomycin for a total of 14 days (7 days remaining when admitted to the long term care facility), a [NAME] (central line access) catheter device was placed at the hospital for the use long term antibiotic administration.
On 04/20/22 at 11:36 AM, Resident #230 was observed in his room. An IV (intravenous) pole with machine was observed in the corner of the room. Resident #230 was asked if he had any type of IV access. Resident #230 started feeling around on his body and under the blankets. The resident was asked again if he had IV access and was asked if there was something in/on his chest area. Resident #230 then started pulling at his shirt. The resident was asked to pull the collar of his shirt down in order to observe. The resident pulled down from his neck, exposing a central line catheter in the right chest wall. The central line catheter had a clear, dry dressing intact dated 04/15/22.
The physician's orders were then reviewed. There were no care orders for the central line access device (dressing changes, IV flush, etc.).
The MARs/TARs (medication/treatment administration records) were reviewed. There were no care orders listed for the central line catheter.
The current care plan documented, .resident will not have complications related to infection .meds/treatments as ordered .IV medications related to C-diff, UTI .If the catheter appears to be lodged in the tissues, an attempt to aspirate any fluid remaining in the catheter can be made in order to lessen the amount of drug at the site. After removing the cannula, elevate the affected arm, notify the physician .and apply a cool compress .
On 04/20/22 at 5:15 PM, the DON (director of nursing), ADON (assistant director of nursing) and the administrator were made aware that Resident #230's baseline care plan did not include the care of the resident's central venous access device, but instead had listed peripheral IV care.
On 04/21/22 at approximately 11:00 AM, the administrator stated, You are right, there is no care plan for central line.
No further information and/or documentation was presented prior to the exit conference on 04/21/22.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0697
(Tag F0697)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on resident interview, staff interview, and clinical record review, the facility staff failed to provide pain management f...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on resident interview, staff interview, and clinical record review, the facility staff failed to provide pain management for 1 of 21 residents in the survey sample, Resident #14. Resident #14 was not administered scheduled Lidocaine 4% patches for 4 consecutive days.
The findings include:
Resident #14 was admitted to the facility with diagnoses including chronic pain syndrome, gastro-esophageal reflux disease (GERD), glaucoma, hypo-osmoliaty, hyponatremia, major depressive disorder, anxiety disorder, hypertension, and joint pain (knees and hands). The most recent MDS dated [DATE] was a quarterly assessment and assessed Resident #14 as cognitively intact for daily decision making with a score of 15 out of 15.
Resident #14 was interviewed on 04/19/2020 at 12:11 p.m. Resident #14 stated there had been 3 to 4 days when the scheduled Lidocaine pain patches were not available for administration. Resident #14 stated, I get 3 of the same patches a day on my knees and shoulder because I have joint pain. From my understanding the medications come from a pharmacy in North Carolina and there was a mix-up in getting them delivered here. Resident #14 was asked about his pain level, Resident #14 stated, It was bearable even at my age. But, it just didn't make sense to me that I missed that many days. I get other pain medications so I'm sure that took some of the edge off.
Resident #14's clinical record incuded the following orders:
Aspercreme Lidocaine 4% Patch. apply to left knee topically in the morning remove at bed time. Start Date: 12/15/2021.
Aspercreme Lidocaine 4% Patch. Apply to left shoulder topically in the morning for pain remove at bedtime. Start Date: 12/09/2021.
Aspercreme Lidocaine 4% Patch. Apply to right knee topically in the morning for pain remove at bedtime. Start Date: 12/09/2021.
Resident #14's medication administration record (MAR) was reviewed and documented on 04/10/2022, 04/11/2022, 04/12/2022, and 04/13/2022, the morning administration of each of the scheduled Aspercreme Lidocaine 4% patch was not administered for the left knee, right knee, and left shoulder. The missed doses were marked as 9, other/see progress notes.
Nursing notes dated 04/10/2022 at 8:28 a.m. documented concerning the medication patches not administered, patch on order. Nursing notes dated 04/11/2022 at 12:16 p.m. documented, Notified NP. Nursing notes dated 04/12/2022 at 8:56 a.m., documented, on order. Nursing notes dated 04/13/2022 at 9:34 a.m. documented, on order. There was no documentation about use of a back-up pharmacy to acquire the medication patches.
Resident #14's care plan documented the following focus area, The resident has pain r/t (related to) neuropathy, DDD (degenerative disc disease), osteoarthritis, and GERD (Rev. 12/12/2021). Goal: The resident will verbalize adequate relief of pain or ability to cope with incompletely relieve pain through review date (Rev. 03/14/2022.). Interventions: . Administer pain medications as ordered and monitor for effectiveness
On 04/20/2022 at 9:39 a.m. the licensed practical nurse (LPN) #3 who routinely provided care for Resident #14 and documented the nursing notes on 04/10/2022, 04/12/2022, and 04/13/2022 was interviewed about the missed doses. LPN #3 stated, There was some recent confusion about pharmacy changes with the patches switching from the pharmacy order to becoming house stock. We were ordering them from the pharmacy and waiting for them delivery and then we found they were switched to a house stock item. You can speak with the unit manager or DON (director of nursing) for more information because there was a meeting to discuss the new house stock items.
On 04/20/2022 at 9:42 a.m., the DON and assistant director of nursing (ADON/RN #3) were interviewed. The DON stated the facility switched to a new pharmacy on January 1, 2022 and the facility had identified a problem with receiving medications. The DON stated the facility recently met with the pharmacy on Monday, 04/18/2022 and identified the house stock list had changed and the facility was not aware of the change. The DON stated, The pharmacy told us to pull from our house stock and we weren't aware the list had grown. Corporate grew the list and they didn't tell us. The DON was asked if the Lidocaine 4% patches were part of the house stock list. The ADON/RN #3 stated, Yes if it's on the house stock list we provided you all. Then it's house stock, but previously they were ordered through the pharmacy.
On 04/20/2022 at 10:11 a.m. the central supply clerk (OS #1) who was responsible for ordering house stock items was interviewed. OS #1 stated, At first I was given a very short list of house stock items. I order weekly for supplies and over the counter (OTC) and house stock medications. We did just get an updated list and I'm told this is probably not all of the OTC/house stock meds. It will probably change again. OS #1 was asked when the Lidocaine 4% patches ordered. OS #1 stated, I spoke with (LPN #3) about the situation and they were ordered about 2 weeks ago. We use the Aspercreme or Salonpas 4% generic brands as house stock. I made sure to give her a large bag of them for the med cart.
A review of the (Hill Valley Corporate - Do Not Supply List, Rev. 04/20/2022) documented the Lidocaine 4% as a house stock item.
The above findings were reviewed with the administrator, DON, and ADON during a meeting on 04/20/2022 at 4:55 p.m.
On 04/21/2022 at 8:55 a.m., the nurse practitioner (OS #4) who routinely provided care for Resident #14 was interviewed. OS #4 stated she honestly did not remember being notified about the patches not being available and it was possible the on-call provider was notified instead. OS #4 continued and stated she had recently started providing care for Resident #14 and knew the resident received a lot of pain medications. However, she was not fully familiar with the resident's history and planned to review the record prior to discussing some possible medication changes. OS #4 was asked how would the missed doses of the Lidocaine patches affect Resident #14. OS #4 stated, (Resident #14) could potentially have pain, but he does receive other pain related medications.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0744
(Tag F0744)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on staff interview and clinical record review, the facility staff failed to develop a dementia care plan for 1 of 21 in th...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on staff interview and clinical record review, the facility staff failed to develop a dementia care plan for 1 of 21 in the survey sample, Resident #13. Resident #13 who was diagnosed with dementia without behavioral disturbance did not have a dementia specific care plan including person centered interventions.
The findings include:
Resident #13 was admitted to the facility with diagnoses that included major depressive disorder, hypertension, type 2 diabetes, atrial fibrillation, dementia without behavioral disturbance, hypothyroidism, hyperlipidemia, dysphasia, and muscle weakness. The most recent minimum data set (MDS) dated [DATE] was a significant change and assessed Resident #13 as severely cognitively impaired with a score of 3 out of 15, having fluctuating periods of inattention and disorganized thinking; and wandering. The MDS documented in Section V- Care Area Assessments (CAA) that Resident #13 should be care planned for Dementia.
Resident #13's clinical record was reviewed on 04/20/2022 and included the following: Quetiapine Fumarate Tablet 50 MG (Seroquel). Give 1 tablet by mouth two times a day for dementia. Order Date: 03/10/2022. Start Date: 03/10/2022.
The medication administration record (MAR) for the period March 2022 through April 2022 documented Resident #13 received the Seroquel as ordered/scheduled.
Observed within the nurse practitioner progress notes was the following: 04/19/2022 .The patient has recently been having behavioral disturbances associated with her dementia and was started on Seroquel. At first the Seroquel was too strong and was being titrated back to a reasonable dose. The patient was given a prescription for p.r.n. (as needed) Ativan to help cover for any breakthrough anxiety or behavioral issues while getting the Seroquel to the correct dose. The plan was to continue the Ativan order for 14 days and then stop it, as the Seroquel does appears to have been reached a therapeutic level and the patient's behaviors have resolved. The patient has not needed the Ativan since 4/2/22. Will discontinue the ativan
On 04/20/2022 at 11:30 a.m., the licensed practical nurse (LPN) #3 who routinely provided care for Resident #13 was interviewed regarding Resident #13's behaviors. LPN #3 stated the resident was readmitted to the unit a couple months ago after a brief hospital stay due to having a stroke. LPN #3 stated after returning to the facility Resident #13 tested positive for COVID and was placed on the facility's COVID unit for a couple of weeks and then returned back to their normal room on the second floor. LPN #3 was asked what behaviors Resident #13 displayed. LPN #3 stated Resident #13 had behaviors of agitation, wandering and refusing care. LPN #3 stated, (Resident #13) has dementia. LPN #3 was asked what interventions were in place for Resident #13. LPN #3 stated, She likes to ambulate with her walker and sit at the end of the hall and look at the window. When she gets agitated we try to figure out why and letting her call her children and/or visit her husband across the hall helps to calm her. LPN #3 was asked who was responsible for the care plans. LPN #3 stated the unit manager.
On 04/20/2022 at 12:30 p.m., the unit manager, registered nurse (RN) #2 was interviewed regarding Resident #13's care plans. RN #2 reviewed the care plans and stated the resident did have a diagnosis of dementia and a dementia specific care plan should have been developed. RN #2 was asked what specific interventions were in place for the resident. RN #2 stated, When (Resident #13) was readmitted after the hospital stay and then transferred to the facility's COVID unit and finally back to her regular room this appeared to bring on more confusion. She now seems back at her baseline. She enjoys walking the unit, likes sitting at the end of the hall, and visiting with her husband.
The above information was shared with the administrator director of nursing (DON) and assistant director of nursing (ADON) during a meeting on 04/20/2022 at 4:55 p.m.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0761
(Tag F0761)
Could have caused harm · This affected 1 resident
Based on observation, staff interview, and facility document review, the facility staff failed to ensure medications and biologicals were dated when opened on two of 4 units, Town Square and The Garde...
Read full inspector narrative →
Based on observation, staff interview, and facility document review, the facility staff failed to ensure medications and biologicals were dated when opened on two of 4 units, Town Square and The Gardens. On the Peaks unit, facility staff failed to ensure an expired medication was not available for administration. A bottle of oral vancomycin (an antibiotic) was dated as do not use beyond 4/18/22 was still in the medication refrigerator.
Findings include:
On 4/20/22 beginning 8:00 a.m. the medication storage inspection was conducted in the facility. On the Town Square unit, the medication refrigerator was inspected with RN (registered nurse) # 4. An vial of tuberculin skin test solution was open with no date recorded on the box or the vial. RN # 4 stated I'm pretty sure that was opened last Wednesday when we sent a patient out .do you want me to date it now? RN # 4 was advised to do whatever the facility policy or procedure was. The medication refrigerator on Peaks unit was inspected with RN # 5. A bottle of vancomycin was observed in the refrigerator with a red label dated 4/18/22 and directed Do not use past this date. RN # 5 was asked about the expired medication, and she stated I will remove that right now. The Gardens unit medication cart was then inspected with LPN (licensed practical nurse) # 1. An opened vial of Lispro insulin was located in the cart, and was not dated when opened. LPN # 1 stated That belongs to a new admission .I can look to see when that came in since that's when it was probably opened .do you want me to date it now? Again, staff were told to follow the facility policy.
On 4/20/22/at 9:30 a.m. the DON (director of nursing) was asked for the facility policy for storing and labeling medications and biologicals.
The policy Medication Storage documented 4. The facility shall not use discontinued, outdated, or deteriorated drugs or biologicals. All such drugs shall be returned to the dispensing pharmacy or destroyed. 5. When the original seal of a manufacturer's container or vial is initially broken, the container or vial will be dated. 5 a. The nurse shall place a 'date opened' sticker on the medication and record the date opened and the new date of expiration. The expiration date of the vial or container will be 30 days from opening, unless the manufacturer recommends another date or regulations/guidelines require different dating. 7. No expired medication will be administered to a resident. 8. All expired medications will be removed from the active supply and destroyed in accordance with facility policy, regardless of amount remaining. The package insert for the PPD solution was provided by the facility and directed A vial of Tubersol which has been entered and in use for 30 days should be discarded. The insulin storage guide directed that once insulin (including Lispro) is removed from the refrigerator it should be dated when removed and is good for 28 days.
The administrator, DON, and ADON (assistant director of nursing) were informed of the above findings during an end of the day meeting 4/20/22 beginning at 4:55 p.m.
No further information was provided prior to the exit conference.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0808
(Tag F0808)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on staff interview and clinical record review, the facility staff failed to have an physician's order for a therapeutic di...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on staff interview and clinical record review, the facility staff failed to have an physician's order for a therapeutic diet for Resident #13. Resident #13's clinical record did not document a nutrition/diet order upon readmission from the hospital.
The findings include:
Resident #13 was admitted to the facility with diagnoses that included major depressive disorder, hypertension, type 2 diabetes, atrial fibrillation, dementia without behavioral disturbance, hypothyroidism, hyperlipidemia, dysphasia, and muscle weakness. The most recent minimum data set (MDS) dated [DATE] was a significant change and assessed Resident #13 as severely cognitively impaired with a score of 3 out of 15, having fluctuating periods of inattention and disorganized thinking; and wandering. The MDS documented in Section V - Care Area Assessments (CAA) that Resident #13 should be care planned for nutritional needs.
Resident #13's electronic health record (EHR) was reviewed on 04/20/2022. A review of EHR and order summary report did not document Resident #13 had an order for nutritional/dietary needs including a therapeutic diet.
On 04/20/2022 at 12:08 p.m. the unit manager, registered nurse (RN) #2, who routinely provided care for Resident #13 was interviewed regarding the resident's EHR and order summary not having a nutritional/dietary orders. RN #2 reviewed Resident 13's EHR and stated she was not aware the order was missing. RN #2 then reviewed Resident #13's paper chart that included the most recent hospital Discharge summary dated [DATE]. RN #2 stated, The hospital discharge summary did not include diet orders for readmission. RN #2 was asked about the process to obtain/verify orders when a resident was admitted or readmitted . RN #2 stated nursing would verify the orders with the physician and if the resident required a speech consult than speech would make recommendations. RN #2 stated Resident #13 was not seen by speech upon readmission to the facility. RN #2 stated Resident #13 was a readmission and a diabetic and it was likely the kitchen used the previous diet orders.
On 04/20/2022 at 3:45 p.m. the dietary manager (OS #2) was interviewed regarding Resident #13's diet orders. OS #2 reviewed the dietary records and stated the resident was receiving a no concentrated sweets diet. OS #2 was asked when this ordered was received. OS #2 stated on 03/03/2022. OS #2 was asked how did he receive the information. OS #2 stated nursing normally faxes or emails the admission/readmission diet orders to the kitchen. OS #2 was advised Resident #13 was readmitted on [DATE]. OS #2 reviewed the orders that were received by the kitchen for February 2022 and March 2022 and stated he could not locate the fax or email communication. OS #2 was asked why the dietary orders were not documented in the EHR. OS #2 stated nursing entered those orders in the (name of EHR system). OS #2 stated he only entered the dietary orders in the kitchen's (menu system) which generated the resident's meal tickets and/or preferences and this was not connected with the EHR.
The above findings were reviewed with the administrator, DON and ADON during a meeting on 04/20/2022 at 4:55 pm.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0849
(Tag F0849)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on staff interview, clinical record review, and facility document review, the facility staff failed to ensure professional...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on staff interview, clinical record review, and facility document review, the facility staff failed to ensure professional standards of practice by a hospice provider for 1 of 21 residents in the survey sample, Resident #35. Records of weekly hospice visits for Resident #35 were not provided to the facility as required in the hospice services agreement.
The findings include:
Resident #35 was admitted to the facility with diagnoses that included anxiety disorder, cirrhosis of the liver, hepatic failure, congestive heart failure, stage 3 kidney disease, type 2 diabetes, hyperlipidemia, and encounter for palliative care (hospice). The most recent minimum data set (MDS) dated [DATE] was a quarterly and assessed Resident #35 as moderately impaired for daily decision making with a score of 11 out of 15. Under Section O - Special Programs and Treatments, the MDS documented Resident #35 was receiving hospice care.
Resident #35 was interviewed on 04/19/2022 at 11:30 a.m. regarding the quality of care and quality of life since being at the facility. Resident #35 stated, I've been here for almost six years and this is home for me. Everyone treats me nice, they answer the call bells and we have so many activities. My only issue is the food. Resident #35 was asked if staff assisted with activities of daily living (ADLs). Resident #35 stated, I can do certain things for myself, but now that I am on hospice I have a hospice aide and nurse who come to visit at least twice a week. The aide will help me with my bathing and dressing.
Resident #35's clinical record was reviewed and observed on the order summary report was a hospice order dated 01/17/2022. A review of Resident #35's care plans documented a focus area including goals and interventions for hospice care.
Resident #35's paper chart was reviewed for the hospice notes. Observed were the hospice assessment, plan of care, medication list, hospice nursing visit notes and certified nursing assistant (CNA) visits sign-off form. The most recent hospice nursing visit note was dated 04/01/2022.
On 04/20/2022 at 10:30 a.m., the unit manager, registered nurse (RN) #2 was interviewed regarding the missing hospice nursing visit notes. RN #2 was asked how often did hospice staff visit and provide/coordinate care for Resident #35. RN #2 stated, Someone usually comes a couple times per week. Usually the CNA will come one day and a nurse will come another day. RN #2 was asked how hospice visit notes were received by the facility once visits were completed. RN #2 stated, The hospice nurse is able to print the notes onsite after the visit. The CNA signs off a separate form that they have visited and provided care to the resident. RN #2 was asked about the most recent hospice nurse visit. RN #2 stated, I honestly can't say because I'm not always here when they visit, but I know someone visits twice weekly. If not we're notified. RN #2 was advised the most recent hospice nursing note was 04/01/2022. RN #2 stated, Someone has definitely visited (Resident #35) weekly, if not we would have been notified. I can't say why the notes weren't printed and filed.
A review of the Nursing Home Agreement For Provision Of Hospice Services signed on 10/29/2021 between the facility and hospice provider documented on 8 the following: . 4. Records: 4/1 Compilation of Records: 4/1/1: Preparation: The Nursing Facility and Hospice shall each prepare and maintain complete and detailed clinical records concerning each Residential Hospice Patient receiving Nursing Facility Services and Hospice Services under this Agreement in accordance with prudent record-keeping procedures and as required by applicable federal and state law and regulations and application Medicare and Medicaid program guidelines. Each clinical record shall completely, promptly and accurately document all services provided to, and events concerning, each Residential Hospice Patient (including evaluations, treatments, progress notes, authorizations to admissions to Hospice and/or the Nursing Facility and physician orders, entered pursuant to the Agreement). The Nursing Facility and Hospice shall cause each entry made for services provided hereunder to be signed by the person providing the services
The above findings were reviewed with the administrator, director of nursing (DON), and assistant director of nursing (ADON) during a meeting on 04/20/2022 at 4:55 p.m.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Notification of Changes
(Tag F0580)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on resident interview, staff interview, clinical record review, and facility document review, the facility staff failed to...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on resident interview, staff interview, clinical record review, and facility document review, the facility staff failed to notify the physician of medications not available for administration for three of 21 residents in the survey sample, Resident #230, Resident #59 and Resident #15.
Findings include:
1. Resident #230 was admitted with diagnoses that included, but were not limited to: BPH (benign prostatic hypertrophy) with urinary retention, indwelling Foley catheter, urinary tract infection, entercolitis, C-Diff (clostridium difficile) infection, PVD (peripheral vascular disease), dementia, high blood pressure and bacteremia (infection in the blood).
The resident's admission MDS (minimum data set) was still in progress. Resident #230's nursing admission assessment dated [DATE] documented, that the resident had dementia with cognitive deficits (unable to answer to place, time and situation).
On 04/20/22 at 11:36 AM, Resident #230 was observed in his room. An IV (intravenous) pole with machine was observed in the corner of the room.
The physician's orders were then reviewed and included the following:
.Aricept tablet 23 mg (milligrams) give one tablet daily in the morning for dementia (order date: 04/15/22) (start date: 04/16/22)
Vancomycin capsule 125 mg give one capsule by mouth four times a day for 8 days for C-diff (order date: 04/15/22) (start date: 04/15/22)
Vancomycin .use 1.75 gram intravenously every 24 hours for C-diff for 7 administrations (order date: 04/15/22) (start date: 04/16/22) .
The MARs/TARs (medication/treatment administration records) were reviewed for the month of April 2022. The MAR documented that Resident #230 did not receive Aricept 23 mg on April 16th, 17th, 18th, or 19th. The resident's progress notes documented that the medication was unavailable, on order, or awaiting from the pharmacy on these days.
The MARs also documented that Resident #230 did not receive oral Vancomycin 125 mg capsules on April 16th (3 doses), April 17th (two doses) and April 19th (one dose). The resident's progress notes documented that the oral Vancomycin was on order from the pharmacy and not available for administration on these days.
The MARs documented that Resident #230 did not receive the IV Vancomycin 1.75 grams IV on April 16th, 17th, 18th, or 19th. The resident's progress notes documented that the IV medication was on order from the pharmacy (04/16/22).
A nursing progress note dated 04/18/22 documented that clarification was needed from the MD (Medical Doctor) regarding this medication. There was no clarification found in the resident's records regarding this medication.
A nursing progress note dated 04/19/22 documented that the IV Vancomycin was on hold related to issues with pharmacy. There was no clarification regarding this, nor were there any physician's orders to hold this medication and no information regarding issues with pharmacy.
Resident #230's current care plan documented, .keep physician informed of any problems .
On 04/20/22 at 9:45 AM, the DON (director of nursing) and the ADON (assistant director of nursing) were interviewed. They were asked what happens if a medication is not available for the nurses to administer. The DON stated, We notify the physician that meds are not available. They were asked if they had been having issues with medications being unavailable for administration. The ADON stated, In the past, yes. The DON stated, Our nurses are still telling us we have problems getting meds that's why we've been having frequent meetings with pharmacy. The DON and ADON stated that they last met with pharmacy in January and the problem was still current. The DON stated, They (pharmacy) say they will call (if meds aren't available), out of stock or on back order .we really don't know either.
On 04/20/22 at 4:45 PM, LPN (Licensed Practical Nurse) #1 was interviewed regarding Resident #230 not being administered the ordered medications. LPN #1 stated that the facility had been having ongoing trouble getting medications from the pharmacy. LPN #1 was asked if she had notified the physician of medications not being available for administration for Resident #230. LPN #1 stated that she had written one of the medications down in the physician's book (did not notify via phone) and that it was initialed as being seen, but there were new orders. LPN #1 stated that she did not notify physician of any other medications not being available to administer or that they were not administered as ordered.
At 4:50 PM, the unit manager, Registered Nurse (RN) #1 was interviewed regarding Resident #230 not getting medications as ordered by the physician. RN #1 stated that the facility has had trouble getting medications for residents and that the facility has switched pharmacies. RN #1 was asked if she had notified the physician of Resident #230 not having medications available for administration and/or that the resident had not received the above medications as ordered. RN #1 stated that she had not notified the physician.
On 04/20/22 at 5:15 PM, the DON (director of nursing), ADON (assistant director of nursing) and the administrator were made aware of concerns regarding Resident #230 not getting medications as ordered by the physician and the physician not being notified. The DON was asked for a policy on physician notification.
A policy titled, Change in a resident's condition documented, .facility will promptly notify the resident, his or her physician/practitioner, and representative of changes in the resident's medical/mental condition and/or status .A need to alter treatment .change in the resident's condition .nurse will notify the resident's attending physician/practitioner .need to alter the resident's medical treatment .refusal of treatment or medications two or more consecutive times .
No further information and/or documentation was presented prior to the exit conference on 04/21/22.
2. Resident #59's was admitted with diagnoses that included: Atrial fibrillation, high blood pressure, depression, polyneuropathy, spinal stenosis, chronic back pain, abdominal pain, abdominal pain, hyponatremia, and constipation.
The most current MDS was an admission assessment dated [DATE]. This MDS assessed the resident with a cognitive score of 14, indicating the resident was intact for daily decision making skills.
Resident #59's clinical records documented in the progress notes that several, physician ordered medications for Resident #59 were not available for administration.
The resident's physician orders included the following:
Dulcolax 5 mg tablet every night at bedtime for laxative (order date: 04/09/22/start date: 0409/22)
Bio-Freeze gel 4% topical for left hip pain apply twice daily (order date: 04/13/22/start date: 04/13/22)
Naproxen tablet 220 mg give one tablet twice daily for inflammation (order date: 04/09/22/start date: 04/09/22)
Magnesium Citrate solution 1.745 grams/30 ml (milliliters) Give 30 ml by mouth in the morning for laxative (order date: 04/09/22/start date: 04/10/22)
Sodium Chloride tablet give one tablet by mouth one time a day for hyponatremia (order date: 04/15/22/start date: 04/16/22).
The MARs/TARs (medication/treatment administration records) for the month of April 2022 indicated Resident #59 did not receive the following medications as ordered by the physician:
Dulcolax 5 mg tablet each night for 9 days.
Eleven of 14 doses of Bio-Freeze gel 4%.
Twenty of 22 ordered doses of the twice daily Naproxen 220 mg.
Magnesium Citrate solution for 5 of 11 days.
Sodium Chloride tablet daily for 6 days.
The progress notes documented that all of the above medications were on order, not available and/or awaiting pharmacy on the days the medication was not administered.
On 04/20/22 at 9:45 AM, the DON (director of nursing) and the ADON (assistant director of nursing) were interviewed. They were asked what happens if a medication is not available for the nurses to administer. The DON stated, We notify the physician that meds are not available. They were asked if they had been having issues with medications being unavailable for administration. The ADON stated, In the past, yes. The DON stated, Our nurses are still telling us we have problems getting meds that's why we've been having frequent meetings with pharmacy. The DON and ADON stated that they last met with pharmacy in January and the problem was still current. The DON stated, They (pharmacy) say they will call (if meds aren't available), out of stock or on back order .we really don't know either.
On 04/20/22 at 11:45 AM, the pharmacy director of quality was interviewed regarding medications being unavailable for Resident #59. The pharmacy director of quality stated that the medications Dulcolax, Magnesium Citrate, Naproxen, Bio-Freeze and Sodium Chloride tablets are all house stock medications and are supplied by the facility, not from the pharmacy.
On 04/20/22 at approximately 12:45 PM, the administrator, DON and ADON were made aware of the above information and concern over medications not available for administration. The DON stated that their house stock medications just recently got updated and they were not made aware.
On 04/21/22 at approximately 11:00 AM, the administrator, DON, and ADON were made aware of the concerns with medications not being available for administration or being administered as ordered by the physician and that the physician was not notified.
No further information and or documentation was provided prior to the exit conference on 04/21/22.3. Resident #15 was admitted to the facility with diagnoses that included bladder-neck obstruction, diabetes, anemia, acute kidney failure, atrial fibrillation, hyperlipidemia, hematuria and hypertension. The minimum data set (MDS) dated [DATE] assessed Resident #15 as cognitively intact.
On 4/19/22 at 2:40 p.m., Resident #15 was interviewed about quality of care in the facility. Resident #15 stated his right ear had been stopped up with wax for over a week. The resident stated staff told him they were going to order drops and then irrigate the ear to remove the wax. The resident stated he had received no drops as of today (4/19/22). Resident #15 stated he had pressure and was not able to hear well out of the right ear due to the impacted wax. The resident described the condition as aggravating.
A nurse practitioner (NP) progress note documented the resident was assessed on 4/12/22 for complaints of right ear wax. This progress note documented, .is complaining of right ear feeling plugged and thinks it is wax build up .On otoscopic exam, right TM (tympanic membrane) obscured by cerumen .Impacted cerumen .debox (Debrox), then flush ear in 5 days .
Resident #15's clinical record documented a physician's order dated 4/13/22 for Debrox solution 6.5% with instructions to instill 4 drops in the right ear two times per day for 5 days for treatment of impacted cerumen.
Nursing notes documented a physician's order dated 4/18/22 to flush ear after 5 days of Debrox drops with use of tepid water due to impacted cerumen in the right ear.
Resident #15's medication administration record (MAR) from 4/13/22 through 4/20/22 documented the Debrox solution was not administered because the drops were not available. MAR notes from 4/12/22 through 4/20/22 documented the Debrox was on order from the pharmacy and Not delivered . There was no entry on the MAR regarding the ear irrigation.
The physician and/or nurse practitioner were not promptly notified about the unavailable Debrox drops or inability to irrigate the resident's ear due to lack of Debrox.
On 4/20/22 at 10:44 a.m., the licensed practical nurse (LPN) #1 caring for Resident #15 was interviewed about the Debrox. LPN #1 stated the Debrox never arrived from pharmacy. LPN #1 stated messages had been sent to the pharmacy about the Debrox with no response. LPN #1 was not aware of any other interventions for the impacted cerumen.
On 4/20/22 at 10:46 a.m., the registered nurse (RN #1) unit manager was interviewed about Resident #15's Debrox. RN #1 stated she was told the Debrox had not been sent from pharmacy. RN #1 stated no other interventions had been initiated about Resident #15's impacted ear wax. RN #1 stated the provider was aware the Debrox was unavailable.
On 4/21/22 at 8:53 a.m., the nurse practitioner (NP - other staff #4) caring for Resident #15 was interviewed about the Debrox. The NP stated she was not notified by nursing about the unavailable drops and incomplete order for ear irrigation. The NP stated, I thought he already had the drops. The NP stated the resident told her about not getting the drops on Monday (4/18/22). The NP stated the drops were needed prior to irrigation of the ear to loosen the impacted wax.
This finding was reviewed with the administrator and director of nursing during a meeting on 4/20/22 at 5:00 p.m.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Comprehensive Care Plan
(Tag F0656)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on staff interview and clinical record review, the facility staff failed to develop a comprehensive care plan (CCP) for 3 ...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on staff interview and clinical record review, the facility staff failed to develop a comprehensive care plan (CCP) for 3 of 21 residents in the survey sample, Resident #28, Resident #13, and Resident #15. Resident #28's CCP did not include a focus area with goals and interventions for the use of antidepressants. Resident #13's CCP did not include a focus area with goals and interventions for nutrition. Resident #15's CCP did not include a focus area with goals and interventions for having an impacted ear related to wax build-up.
The findings include:
1. Resident #28 was admitted to the facility with cerebral infarction, major depressive disorder, anemia, hypertension, dysphasia, adult failure to thrive, hemiplegia and hemiparesis, and heart disease. The most recent minimum data set (MDS) dated [DATE] was a 5-day significant change and assessed Resident #28 as having long and short term memory problems, severely impaired for daily decision-making, having hallucinations and delusions; and fluctuating periods of inattention and disorganized thinking.
Resident #28's clinical record was reviewed on 04/20/2022. Observed on the order summary report were the following orders: Escitalopram Oxalate (Lexapro) Tablet 20 MG (milligrams). Give 1 tablet by mouth in the morning for depression. Order Date: 04/04/2022. Start Date: 04/05/2022 .Remeron Tablet (Mirtazapine) Give 7.5 mg by mouth at bedtime for Depression. Order Date: 02/09/2022. Start Date: 02/09/2022.
Resident #28's medication administration record (MAR) was reviewed for the period of months of February through April 2022 and documented Resident #28 received both antidepressants as ordered.
Resident #28's CCP was reviewed and did not include a focus area with goals and interventions for the use of the antidepressants, Escitalopram Oxalate (Lexapro) and Remeron.
On 04/20/2022 at 12:13 p.m., the unit manager (RN #2) who routinely provided care for Resident #28 was interviewed regarding Resident #28's care plans. RN #2 reviewed Resident #28's electronic clinical record and stated the care plans should have been developed for the antidepressant medication use.
The above findings were reviewed with the administrator, director of nursing (DON) and assistant director of nursing (ADON) during a meeting on 04/20/2022 at 4:55 p.m.
2. Resident #13 was admitted to the facility with diagnoses that included major depressive disorder, hypertension, type 2 diabetes, atrial fibrillation, dementia without behavioral disturbance, hypothyroidism, hyperlipidemia, dysphasia, and muscle weakness. The most recent minimum data set (MDS) dated [DATE] was a significant change and assessed Resident #13 as severely cognitively impaired with a score of 3 out of 15, having fluctuating periods of inattention and disorganized thinking; and wandering. The MDS documented in Section V - Care Area Assessments (CAA) that Resident #13 should be care planned for nutritional needs.
Resident #13's clinical record was reviewed on 04/20/2022. A review of clinical record did not document Resident
#13 had a comprehensive care plan (CCP) for nutritional needs including a therapeutic diet.
On 04/20/2022 at 12:08 p.m. the unit manager (RN #2) who routinely provided care for Resident #13 was interviewed regarding the resident's clinical record not having a nutritional care plans. RN #2 reviewed Resident
#13's paper (hard) copy of the clinical record and stated the discharge summary from the most recent hospital stay dated 02/19/2022 did not include dietary orders. RN #2 was asked what was the process to determine the resident's nutritional/diet orders. RN #2 stated Resident #13 was a readmission and a diabetic and it was likely the kitchen used the previous diet order since the resident had a short hospital stay and was readmitted to the facility.
On 04/20/2022 at 4:00 p.m., RN #2 was interviewed a second time. RN #2 stated she reviewed the record with the MDS coordinator and they both believed the staff used the previous diet orders which was a no concentrated sweet because the resident is a diabetic.
On 04/20/2022 at 4:40 p.m., the MDS coordinator (LPN # 2) was interviewed regarding Resident #13's nutritional care plans. LPN #2 reviewed the clinical record and stated the nutritional risk assessment dated [DATE] should have triggered for a nutritional care plan to be completed.
The above findings were reviewed with the administrator, DON & ADON during a meeting on 04/20/2022 at 4:55 pm. 3. Resident #15 was admitted to the facility with diagnoses that included bladder-neck obstruction, diabetes, anemia, acute kidney failure, atrial fibrillation, hyperlipidemia, hematuria and hypertension. The minimum data set (MDS) dated [DATE] assessed Resident #15 as cognitively intact.
On 4/19/22 at 2:40 p.m., Resident #15 was interviewed about quality of care in the facility. Resident #15 stated his right ear had been stopped up with wax for over a week. The resident stated staff told him they were going to order drops and then irrigate the ear to remove the wax. The resident stated he had received no drops as of today (4/19/22). Resident #15 stated he had pressure and was not able to hear well out of the right ear due to the impacted wax. The resident described the condition as aggravating. Resident #15 stated he had reported to nurses and the nurse practitioner that he had not received drops and nothing had been done to relieve the ear wax.
A nurse practitioner (NP) progress note documented the resident was assessed on 4/12/22 for complaints of right ear wax. This progress note documented, .is complaining of right ear feeling plugged and thinks it is wax build up .On otoscopic exam, right TM (tympanic membrane) obscured by cerumen .Impacted cerumen .debox (Debrox), then flush ear in 5 days .
Resident #15's clinical record documented a physician's order dated 4/13/22 for Debrox solution 6.5% with instructions to instill 4 drops in the right ear two times per day for 5 days for treatment of impacted cerumen. Nursing notes documented a physician's order dated 4/18/22 to flush ear after 5 days of Debrox drops with use of tepid water due to impacted cerumen in the right ear.
Resident #15's medication administration record (MAR) from 4/13/22 through 4/20/22 documented the Debrox solution was not administered because the drops were not available. MAR notes from 4/12/22 through 4/20/22 documented the Debrox was on order from the pharmacy and Not delivered . There was no entry on the MAR regarding the ear irrigation.
Resident #15's plan of care (revised 3/8/22) included no problems, goals and/or interventions regarding the impacted ear wax and the ear discomfort described by the resident as aggravating.
On 4/20/22 at 3:04 p.m., the unit manager (RN #1) was interviewed about a care plan for impacted wax. RN #1 stated no care plan had been developed regarding the ear wax and/or ear discomfort. RN #1 stated unit managers were responsible for entering and updating care plans.
This finding was reviewed with the administrator and director of nursing during a meeting on 4/20/22 at 5:00 p.m.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0658
(Tag F0658)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 2. Resident #23 was admitted to the facility with diagnoses to include, but not limited to: COVID-19, osteoarthritis, and vitami...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 2. Resident #23 was admitted to the facility with diagnoses to include, but not limited to: COVID-19, osteoarthritis, and vitamin D deficiency. The most recent MDS (minimum data set) was a significant change assessment dated [DATE] and had the resident scored as cognitively intact with a score of 14 out of 15.
The clinical record was reviewed 4/20/22 at approximately 2:00 p.m. An order on the current POS (physician order summary) with a start date of 3/30/22 directed CefTRIAXone (sic) Sodium Solution Reconstituted 1 gram Inject 1 gram intramuscularly every 24 hours for infection for 5 days mix in 2.1 ml (milliliters) lidocaine (a numbing agent) 1%.
Review of the MAR (medication administration record) revealed the injections were completed, but one staff on 4/2/22 documented the injection was given in the arm.
The package insert was reviewed for information about the injection, and documented in bold print, capitol letters, DO NOT GIVE IN THE DELTOID. (The deltoid is in the upper arm).
The pharmacist, other staff (OS) # 5, was interviewed and asked about the IM injection given in the arm. OS # 5 stated If you can give me the resident name, I can see which formula she was given. OS # 5 then stated Yes, it says here on the medical information sheet it is not to be given in the deltoid, but given deep IM in the gluteal (buttock) area.
On 4/20/22 the DON (director of nursing) and the ADON (assistant director of nursing) were interviewed. The ADON stated Well, the order says to inject intramuscularly, but doesn't say where . The DON was then asked for a policy on injections as related to what medication was to be given, and what her expectation was for staff to be knowledgeable about what was given. The DON stated I expect them to look up the medication if there is any question about giving it . The DON was then asked, seeing the medication was mixed with Lidocaine, and the resident being thin, was that correct giving a deep IM injection in the arm. She stated No.
The policy presented Adverse Consequences and Medication Errors directed under #5. Examples of medication errors include:h. Failure to follow manufacturer instructions and /or accepted professional standards . 7. a. The dose, route of administration, duration, and monitoring are in agreement with current clinical practice, clinical guidelines, and/or manufacturer's specifications for use.
The administrator, DON, and ADON (assistant director of nursing) were informed of the above findings during an end of the day meeting 4/20/22 beginning at 4:55 p.m.
No further information was provided prior to the exit conference.3. Resident #230 was admitted with diagnoses that included, but were not limited to: BPH (benign prostatic hypertrophy) with urinary retention, indwelling Foley catheter, urinary tract infection, entercolitis, C-Diff (clostridium difficile) infection, PVD (peripheral vascular disease), dementia, high blood pressure and bacteremia (infection in the blood).
The resident's admission MDS (minimum data set) was still in progress. Resident #230's nursing admission assessment dated [DATE] documented, that the resident had dementia with cognitive deficits (unable to answer to place, time and situation).
On 04/20/22 at 11:36 AM, Resident #230 was observed in his room. An IV (intravenous) pole with machine was observed in the corner of the room. Resident #230 was asked if he had any type of IV access. Resident #230 started feeling around on his body and under the blankets. The resident was asked again if he had IV access and was asked if there was something in/on his chest area. Resident #230 then started pulling at his shirt. The resident was asked to pull the collar of his shirt down in order to observe. The resident pulled down from his neck, exposing a central line catheter in the right chest wall. The central line catheter had a clear, dry dressing intact dated 04/15/22.
The physician's orders were reviewed and included the following:
Vancomycin capsule 125 mg give one capsule by mouth four times a day for 8 days for C-diff (order date: 04/15/22) (start date: 04/15/22)
Vancomycin .use 1.75 gram intravenously every 24 hours for C-diff for 7 administrations (order date: 04/15/22) (start date: 04/16/22) .
The MARs/TARs (medication/treatment administration records) documented that Resident #230 did not receive the IV Vancomycin 1.75 grams IV on April 16th, 17th, 18th, or 19th.
A nursing progress note documented that the IV medication was on order from the pharmacy (04/16/22). A nursing progress note dated 04/18/22 documented that clarification was needed from the MD (Medical Doctor) regarding this medication. There was no clarification found in the resident's records regarding this medication.
A nursing progress note dated 04/19/22 documented that the IV Vancomycin was on hold related to issues with pharmacy. There was no clarification regarding this, nor were there any physician's orders to hold this medication and no information regarding issues with pharmacy.
On 04/20/22 at 9:45 AM, the DON (director of nursing) and the ADON (assistant director of nursing) were interviewed. They were asked what happens if a medication is not available for the nurses to administer. The DON stated, We notify the physician that meds are not available. They were asked if they had been having issues with medications being unavailable for administration. The ADON stated, In the past, yes. The DON stated, Our nurses are still telling us we have problems getting meds that's why we've been having frequent meetings with pharmacy. The DON and ADON stated that they last met with pharmacy in January and the problem was still current. The DON stated, They (pharmacy) say they will call (if meds aren't available), out of stock or on back order .we really don't know either.
On 04/20/22 at 11:35 AM, the pharmacy director of quality was interviewed regarding the IV Vancomycin being unavailable for Resident #230, since being admitted to the facility (4 days). The pharmacy director stated that the IV Vancomycin request was sent to the pharmacy on 04/16/22 and the pharmacist had attached a note that documented that the medication was ordered for C-diff (not a blood infection per the resident's hospital discharge summary) and that the medication had been profiled for that reason. The pharmacy director stated that Resident #230 also had an order for oral Vancomycin for C-diff, and that antibiotics aren't ordered IV and by mouth for C-diff. The pharmacy director was made aware that Resident #230's hospital discharge summary listed the oral Vancomycin for C-diff and the IV Vancomycin for the blood infection. The pharmacy director stated that Resident #230 was on oral Vancomycin for C-diff and that IV Vancomycin isn't typically ordered for C-diff, but that is what the facility had put in when they submitted the order to the pharmacy. The pharmacy director stated that it appeared that the diagnoses was input incorrectly for the IV Vancomycin and that should have been clarified somewhere. The pharmacy director was made aware of progress notes documenting the need for clarification and issues with the pharmacy regarding the IV medication, but there was no evidence of any clarification or follow up, either by nursing or the pharmacy.
On 04/20/22 at 5:15 PM, the DON (director of nursing), ADON (assistant director of nursing) and the administrator were made aware of concerns regarding Resident #230 not getting medications as ordered by the physician and that according to the pharmacy, the medication diagnosis was incorrect, which had stopped the medication from being filled and delivered as ordered. The ADON stated that she had input the orders in for Resident #230 and that the nurse giving her report from the hospital told her the IV medication was for C-diff. The ADON stated that she did not have access to the hospital discharge summary at that time to see what the medication was ordered for, and went by the information she was given in report.
A policy was requested for new admissions/transfer orders and/or order transcription to ensure medication orders are entered correctly for new/re- admissions.
A policy titled, Ordering and Receiving non-controlled Medications documented, .The facility maintains accurate records of medication order and receipt .written on a physician's order form, telephone order sheet, or reorder form .written in the chart by the physician, or entered into the facility's EHR (electronic health record) and transmitted to the pharmacy .date of order whether the order is new or a repeat order (refill) .include the prescription number .medication name, strength, when indicated, indication for use .directions for use .when phoning in, sending electronically, or faxing a medication order to the pharmacy, the following information must be given: resident's names and other identifying information, medication name, complete order if new, name of prescribers .indication for use, Name of person calling in order .calling/faxing/sending electronically medication orders for a newly admitted /readmitted resident, the pharmacy is also given all allergies, and diagnoses to facilitate generation of a patient profile and permit initial medication use assessment .
No further information was presented prior to the exit conference on 04/21/22.
Based on staff interview, facility document review and clinical record review, the facility staff failed to follow professional standards of practice for three of twenty-one residents in the survey sample, Resident #15, #23, and #230.
A nurse administered the medication Depakote to Resident #15 in error. There was no report or investigation of the error by nursing administration.
Resident #23 was administered a deep IM (intramuscular) injection of an antibiotic in the deltoid muscle which was against the manufacturer's recommendation.
The facility failed to accurately transcribe a physician's order resulting in Resident #230 missing an IV (intravenous) antibiotic (Vancomycin) for four days.
The findings include:
1. Resident #15 was admitted to the facility with diagnoses that included bladder-neck obstruction, diabetes, anemia, acute kidney failure, atrial fibrillation, hyperlipidemia, hematuria and hypertension. The minimum data set (MDS) dated [DATE] assessed Resident #15 as cognitively intact.
Resident #15's clinical record documented a nursing note on 2/27/22 stating, Patient was accidentally given a medication that was not on his chart. Depakote was administered around 2330 (11:30 p.m.). On-call (nurse practitioner) was notified as well as his family .
A nurse practitioner progress note dated 2/28/22 documented, .The patient was seen today at the request of nursing following a med (medication) error .the patient was given a dose of Depakote meant for another patient by accident. Depakote will be fully processed through the body in 40 hours .Staff to monitor vital signs and watch for side effects for 40 hours .monitor for 40 hours following accidental ingestion of Depakote .
Resident #15 had no physician's order for Depakote. The clinical record did not document the Depakote dosage that was administered in error.
On 4/20/22 at 4:30 p.m., the licensed practical nurse (LPN #1) caring for Resident #15 was interviewed about the medication error. LPN #1 stated she was not aware of the medication error. LPN #1 reviewed the nursing notes and stated the med error was documented by a night shift nurse.
On 4/20/22 at 4:41 p.m., the registered nurse unit manager (RN #1) was interviewed about the Depakote administered to Resident #15. RN #1 stated she was not aware of a medication error involving Resident #15. RN #1 stated, I don't recall knowing that.
This finding was reviewed with the administrator and director of nursing (DON) during a meeting on 4/20/22 at 5:00 p.m. The DON stated at this time that she was not aware Depakote was administered to Resident #15 in error. The DON stated nurses were required to complete an incident form for any medication errors.
On 4/21/22 at 10:47 a.m., the assistant director of nursing (RN #3) stated no incident form was entered regarding the 2/27/22 medication error and no investigation had been done. RN #3 stated she had no explanation of what happened and thought the nurse may be have distracted and busy.
The facility's policy titled Adverse Consequences and Medication Errors (undated) documented, .Medication Error is defined as the preparation or administration of drugs or biological which is not in accordance with physician's orders .Examples of mediations (medication) errors include .unauthorized drug - a drug is administered without a physician's order .The DON or designee will conduct a root cause analysis of medication administration errors to determine the source of errors, implement process improvement steps, and compare results over time to determine that system improvements are effective in reducing errors .
The Nursing 2022 Drug Handbook on pages 1492 and 1493 describes Depakote as an anticonvulsant medication used for the treatment of seizures, mania and migraine headaches with possible adverse reactions such as dizziness, drowsiness, insomnia and rash. Page 17 of this reference documents concerning the eight rights of medication administration, .These are broadly stated goals and practices to help individual nurses administer drugs safely and correctly .2. The right patient: Confirm the patient's identify by checking two patient identifiers . (1)
(1) Woods, [NAME] Dabrow. Nursing 2022 Drug Handbook. Philadelphia: Wolters Kluwer, 2022.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Quality of Care
(Tag F0684)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 5. Resident #14 was admitted to the facility with diagnoses including chronic pain syndrome, gastro-esophageal reflux disease (G...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 5. Resident #14 was admitted to the facility with diagnoses including chronic pain syndrome, gastro-esophageal reflux disease (GERD), glaucoma, hypo-osmoliaty, hyponatremia, major depressive disorder, anxiety disorder, hypertension, and joint pain (knees and hands). The most recent MDS dated [DATE] was a quarterly assessment and assessed Resident #14 as cognitively intact for daily decision making with a score of 15 out of 15.
Resident #14 was interviewed on 04/19/2020 at 12:11 p.m. During the interview Resident #14 stated there had been 3-4 days when the scheduled Lidocaine pain patches were not available for administration. Resident #14 stated, I get 3 of the same patches a day on my knees and shoulder because I have joint pain. From my understanding the medications come from a pharmacy in North Carolina and there was a mix-up in getting them delivered here. Resident #14 was asked about his pain level, Resident #14 stated, it was bearable even at my age. But, it just didn't make sense to me that I missed that many days. I get other pain medications so I'm sure that took some of the edge off.
Resident #14's clinical record was reviewed and observed on the order summary sheet was the following orders:
Aspercreme Lidocaine 4% Patch. apply to left knee topically in the morning remove at bed time. Start Date: 12/15/2021.
Aspercreme Lidocaine 4% Patch. Apply to left shoulder topically in the morning for pain remove at bedtime. Start Date: 12/09/2021.
Aspercreme Lidocaine 4% Patch. Apply to right knee topically in the morning for pain remove at bedtime. Start Date: 12/09/2021.
Resident #14's medication administration record (MAR) was reviewed and documented on 04/10/2022, 04/11/2022, 04/12/2022, and 04/13/2022, the morning administration of each of the scheduled Aspercreme Lidocaine 4% patch was not administered for the left knee, right knee, and left shoulder. The missed doses were marked as 9, other/see progress notes.
Nursing notes dated 04/10/2022 at 8:28 a.m. documented concerning the medication patches not administered, patch on order. Nursing notes dated 04/11/2022 at 12:16 p.m. documented, Notified NP. Nursing notes dated 04/12/2022 at 8:56 a.m., documented, on order. Nursing notes dated 04/13/2022 at 9:34 a.m. documented, on order. There was no documentation about the use of a back-up pharmacy to acquire the medication patches.
Resident #14's care plan documented the following focus area, The resident has pain r/t (related to) neuropathy, DDD (degenerative disc disease), osteoarthritis, and GERD (Rev. 12/12/2021). Goal: The resident will verbalize adequate relief of pain or ability to cope with incompletely relieve pain through review date (Rev. 03/14/2022.). Interventions: . Administer pain medications as ordered and monitor for effectiveness
On 04/20/2022 at 9:39 a.m. the licensed practical nurse (LPN) #3 who routinely provided care for Resident #14 and documented the nursing notes on 04/10/2022, 04/12/2022, and 04/13/2022 was interviewed about the missed doses. LPN #3 stated, There was some recent confusion about pharmacy changes with the patches switching from the pharmacy order to becoming house stock. We were ordering them from the pharmacy and waiting for delivery and then we found they were switched to a house stock item. You can speak with the unit manager or DON (director of nursing) for more information because there was a meeting to discuss the new house stock items.
On 04/20/2022 at 9:42 a.m., the DON and assistant director of nursing (ADON/RN #3) were interviewed. The DON stated the facility switched to a new pharmacy on January 1, 2022 and the facility had identified a problem with receiving medications. The DON shared the facility recently met with the pharmacy on Monday, 04/18/2022 and identified the house stock list had changed and the facility was not aware of the change. The DON stated, The pharmacy told us to pull from our house stock and we weren't aware the list had grown. Corporate grew the list and they didn't tell us. The DON was asked if the Lidocaine 4% patches were part of the house stock list. The ADON/RN #3 stated, Yes if it's on the house stock list we provided you all. Then it's house stock, but previously they were ordered through the pharmacy.
On 04/20/2022 at 10:11 a.m. the central supply clerk (OS #1) who was responsible for ordering house stock items was interviewed. OS #1 stated, At first I was given a very short list of house stock items. I order weekly for supplies and over the counter (OTC) and house stock medications. We did just get an updated list and I'm told this is probably not all of the OTC/house stock meds. It will probably change again. OS #1 was asked when the Lidocaine 4% patches ordered. OS #1 stated, I spoke with (LPN #3) about the situation and they were ordered about 2 weeks ago. We use the Aspercreme or Salonpas 4% generic brands as house stock. I made sure to give her a large bag of them for the med cart.
On 04/20/2022 at 11:34 a.m. the pharmacy representative (OS #5) was interviewed and stated, .the facility is responsible for house items not the pharmacy
A review of the (Hill Valley Corporate - Do Not Supply List - Rev. 4/20/2022) documented the Lidocaine 4% as a house stock item.
The above findings were reviewed with the administrator, DON, and ADON during a meeting on 04/20/2022 at 4:55 p.m.
On 04/21/2022 at 8:55 a.m., the nurse practitioner (OS #4) who routinely provided care for Resident #14 was interviewed. OS #4 stated she honestly did not remember being notified about the patches not being available and it was possible the on-call provider was notified instead. OS #4 continued and stated she had recently started providing care for Resident #14 and knew the resident received a lot of pain medications. However, she was not fully familiar with the resident's history and planned to review the record prior to discussing some possible medication changes. OS #4 was asked how would the missed doses of the Lidocaine patches affect Resident #14. OS #4 stated, (Resident #14) could potentially have pain, but he does receive other pain related medications. 6. On 4/20/22 beginning at 8:00 a.m. the blood glucose monitoring quality control logs were reviewed on Town Square unit. The controls were not documented as done daily. Registered nurse (RN) # 4 was asked if the controls were to be done daily. RN # 4 stated The night shift nurse does the controls. I think they only have to be done every 2-3 days .
On the Peaks unit, blood glucose monitoring logs were reviewed and the controls were not documented as done daily. RN # 5 stated the night shift performed the controls.
On The Gardens unit, LPN (licensed practical nurse) # 1 was asked for the control logs for the unit. She began looking for them, then stated I can't find them. Let me go ask (name of RN # 1) if she knows where they are. RN # 1 then came to the nurses' station and began looking for the logs. She stated I don't know where they are. Let me call (name of night nurse) and see where those are kept.
On 4/20/22/at 9:30 a.m. the DON (director of nursing) was asked for the facility policy for blood glucose monitoring quality control. The policy Blood Glucose Monitors- Quality Control Checks directed Documentation: 1. The facility staff will document blood glucose monitor control checks for each blood glucose monitor daily.
The administrator, DON, and ADON (assistant director of nursing) were informed of the above findings during an end of the day meeting 4/20/22 beginning at 4:55 p.m.
On 4/21/21 at approximately 10:00 a.m. the DON stated that a couple of quality control checks were written down, but not on the log. The logs for The Gardens unit was not located.
No further information was provided prior to the exit conference.
Based on observation, resident interview, staff interview, clinical record review, and facility document review, the facility staff failed to ensure six of 21 residents in the survey sample were administered medications as ordered by the physician, Resident #230, #59, #15, #46, and #14; and failed to ensure glucometer calibration monitoring was completed on three of 4 nursing units, The Gardens, [NAME] Square, and The Peaks.
1. Resident #230 was not administered IV (intravenous) Vancomycin, oral Vancomycin, or Aricept as ordered by the physician.
2. Resident #59 was not administered a sodium chloride supplement or medications for a bowel regimen as ordered by the physician.
3. Resident #15 had no prescribed medication/irrigation treatment for impacted ear wax for over a week, as ordered by the provider, was not administered the medication lisinopril as ordered by the physician, and was administered the medication Depakote in error.
4. Resident #46 was not administered the medications Aricept and Remeron as ordered by the physician.
5. Resident # 14 was not administered scheduled pain patches for 4 consecutive days.
6. The facility staff failed to document blood glucose monitor quality control checks on a daily basis. Two of 4 units (Town Square and Peaks) glucose monitor logs did not have daily documentation of the quality controls, and one unit (The Gardens) did not have quality control logs available for review.
Findings include:
1. Resident #230 was admitted with diagnoses that included, but were not limited to: BPH (benign prostatic hypertrophy) with urinary retention, indwelling Foley catheter, urinary tract infection, entercolitis, C-Diff (clostridium difficile) infection, PVD (peripheral vascular disease), dementia, high blood pressure and bacteremia (infection in the blood).
The resident's admission MDS (minimum data set) was still in progress. Resident #230's nursing admission assessment dated [DATE] documented, that the resident had dementia with cognitive deficits (unable to answer to place, time and situation).
On 04/20/22 at 11:36 AM, Resident #230 was observed in his room. An IV (intravenous) pole with machine was observed in the corner of the room. Resident #230 was observed with a central line catheter that had a clear, dry dressing intact dated 04/15/22.
The physician's orders were then reviewed and included the following:
.Aricept tablet 23 mg (milligrams) give one tablet daily in the morning for dementia (order date: 04/15/22) (start date: 04/16/22)
Vancomycin capsule 125 mg give one capsule by mouth four times a day for 8 days for C-diff (order date: 04/15/22) (start date: 04/15/22)
Vancomycin .use 1.75 gram intravenously every 24 hours for C-diff for 7 administrations (order date: 04/15/22) (start date: 04/16/22) .
The MARs/TARs (medication/treatment administration records) were reviewed for the month of April 2022. The MAR documented that Resident #230 did not receive Aricept 23 mg on April 16th, 17th, 18th, or 19th. The resident's progress notes documented that the medication was unavailable, on order, or awaiting from the pharmacy on these days.
The MARs also documented that Resident #230 did not receive oral Vancomycin 125 mg capsules on April 16th (3 doses), April 17th (two doses) and April 19th (one dose). The resident's progress notes documented that the oral Vancomycin was on order from the pharmacy and not available for administration on these days.
The MARs documented that Resident #230 did not receive the IV Vancomycin 1.75 grams IV on April 16th, 17th, 18th, or 19th. The resident's progress notes documented that the IV medication was on order from the pharmacy (04/16/22).
A nursing progress note dated 04/18/22 documented that clarification was needed from the MD (Medical Doctor) regarding this medication. There was no clarification found in the resident's records regarding this medication.
A nursing progress note dated 04/19/22 documented that the IV Vancomycin was on hold related to issues with pharmacy. There was no clarification regarding this, nor were there any physician's orders to hold this medication and no information regarding issues with pharmacy.
On 04/20/22 at 9:45 AM, the DON (director of nursing) and the ADON (assistant director of nursing) were interviewed. They were asked what happens if a medication is not available for the nurses to administer. The DON stated, We notify the physician that meds are not available. They were asked if they had been having issues with medications being unavailable for administration. The ADON stated, In the past, yes. The DON stated, Our nurses are still telling us we have problems getting meds that's why we've been having frequent meetings with pharmacy. The DON and ADON stated that they last met with pharmacy in January and the problem was still current. The DON stated, They (pharmacy) say they will call (if meds aren't available), out of stock or on back order .we really don't know either.
On 04/20/22 at 11:35 AM, the pharmacy director of quality was interviewed regarding the IV Vancomycin being unavailable for Resident #230, since being admitted to the facility (4 days). The pharmacy director stated that the IV Vancomycin request was sent to the pharmacy on 04/16/22 and the pharmacist had attached a note that the medication was ordered for C-diff (not a blood infection per the resident's hospital discharge summary) and that the medication had been profiled for that reason. The pharmacy director stated the oral Vancomycin 125 mg order was requested and processed on 04/16/22 and 32 capsules (a supply to administer 4 capsules per day for 8 days-as ordered) were delivered on 04/17/22. The pharmacy director was made aware that Resident #230's hospital discharge summary listed the oral Vancomycin for C-diff and the IV Vancomycin for the blood infection. The pharmacy director stated that IV Vancomycin is not well absorbed and isn't typically used to treat C-diff. The pharmacy director stated that it appeared the diagnoses was input incorrectly for the IV Vancomycin and the oral form of the medication was sent and available for administration according to the dispensing records. The pharmacy director was made aware of progress notes documenting the need for clarification and issues with the pharmacy regarding the IV medication, but there was no evidence of any clarification or follow up, order to hold, or any notification to the physician that the resident was not administered the IV Vancomycin as ordered.
The pharmacy director stated that the Aricept was dispensed on 04/16/22, but not delivered to the facility until 04/19/22, and was unsure why there was a delay in delivery.
On 04/20/22 at 4:45 PM, LPN (Licensed Practical Nurse) #1 was interviewed regarding Resident #230 not being administered the ordered medications. LPN #1 stated that the facility had been having ongoing trouble getting medications from the pharmacy. LPN #1 stated that they do carry some medications in they pyxis machine, but not everything that they may need, and that the facility does have house stock meds.
At 4:50 PM, the unit manager, Registered Nurse (RN) #1 was interviewed regarding Resident #230 not getting medications as ordered by the physician. RN #1 stated that the facility has had trouble getting medications for residents and that the facility has switched pharmacies.
On 04/20/22 at 5:15 PM, the DON (director of nursing), ADON (assistant director of nursing) and the administrator were made aware of concerns regarding Resident #230 not getting medications as ordered by the physician and that according to the pharmacy, some medications were here to be administered, while others required clarification. The DON was asked for a policy on unavailable medications.
A policy titled, Unavailable Medications documented, .Medication used by residents in the nursing facility may be unavailable for dispensing from pharmacy on occasion .due to .out of stock .recall .manufacturer's shortage .medication no longer being produced. The facility must make every effort to ensure that medications are available to meet the needs of each resident .pharmacy staff shall .notify nursing staff that the order product is unavailable .when it is anticipated .will be become available .comparable drugs .dosage of drugs .are available .nursing staff shall .notify the attending physician .notify nursing supervisor .or contact facility director for orders and/or direction .
No further information and/or documentation was presented prior to the exit conference on 04/21/22.
2. Resident #59's was admitted with diagnoses that included: Atrial fibrillation, high blood pressure, depression, polyneuropathy, spinal stenosis, chronic back pain, abdominal pain, abdominal pain, hyponatremia, and constipation.
The most current MDS was an admission assessment dated [DATE]. This MDS assessed the resident with a cognitive score of 14, indicating the resident was intact for daily decision making skills.
Resident #59's clinical records documented in the progress notes that several, physician ordered medications for Resident #59 were not available for administration.
The resident's physician orders included the following:
Dulcolax 5 mg tablet every night at bedtime for laxative (order date: 04/09/22/start date: 0409/22)
Bio-Freeze gel 4% topical for left hip pain apply twice daily (order date: 04/13/22/start date: 04/13/22)
Naproxen tablet 220 mg give one tablet twice daily for inflammation (order date: 04/09/22/start date: 04/09/22)
Magnesium Citrate solution 1.745 grams/30 ml (milliliters) Give 30 ml by mouth in the morning for laxative (order date: 04/09/22/start date: 04/10/22)
Sodium Chloride tablet give one tablet by mouth one time a day for hyponatremia (order date: 04/15/22/start date: 04/16/22).
The MARs/TARs (medication/treatment administration records) for the month of April 2022 indicated Resident #59 did not receive the following medications as ordered by the physician:
Dulcolax 5 mg tablet each night for 9 days.
Eleven of 14 doses of Bio-Freeze gel 4%.
Twenty of 22 ordered doses of the twice daily Naproxen 220 mg.
Magnesium Citrate solution for 5 of 11 days.
Sodium Chloride tablet daily for 6 days.
The progress notes documented that all of the above medications were on order, not available and/or awaiting pharmacy on the days the medication was not administered.
On 04/20/22 at 9:45 AM, the DON (director of nursing) and the ADON (assistant director of nursing) were interviewed. They were asked what happens if a medication is not available for the nurses to administer. The DON stated, We notify the physician that meds are not available. They were asked if they had been having issues with medications being unavailable for administration. The ADON stated, In the past, yes. The DON stated, Our nurses are still telling us we have problems getting meds that's why we've been having frequent meetings with pharmacy. The DON and ADON stated that they last met with pharmacy in January and the problem was still current. The DON stated, They (pharmacy) say they will call (if meds aren't available), out of stock or on back order .we really don't know either.
On 04/20/22 at 11:45 AM, the pharmacy director of quality was interviewed regarding medications being unavailable for Resident #59. The pharmacy director of quality stated that the medications Dulcolax, Magnesium Citrate, Naproxen, Bio-Freeze and Sodium Chloride tablets are all house stock medications and are supplied by the facility, not from the pharmacy.
On 04/20/22 at approximately 12:45 PM, the administrator, DON and ADON were made aware of the above information and concern over medications not available for administration. The DON stated that their house stock medications just recently got updated and they were not made aware.
A policy titled, House - Supplied (Floor Sock) Medications documented, .The floor stock medication list is posted in the medication rooms/carts .and provided to the dispensing pharmacy .floor stock medications are ordered from the contracted supplier .
On 04/21/22 at approximately 11:00 AM, the administrator, DON, and ADON were made aware of the concerns with medications not being available or administered as ordered. The administrator stated that they are working on it.
No further information and/or documentation was provided prior to the exit conference on 04/21/22.3. Resident #15 was admitted to the facility with diagnoses that included bladder-neck obstruction, diabetes, anemia, acute kidney failure, atrial fibrillation, hyperlipidemia, hematuria and hypertension. The minimum data set (MDS) dated [DATE] assessed Resident #15 as cognitively intact.
a) Resident #15's clinical record documented a nursing note on 2/27/22 stating, Patient was accidentally given a medication that was not on his chart. Depakote was administered around 2330 (11:30 p.m.). On-call (nurse practitioner) was notified as well as his family .
A nurse practitioner progress note dated 2/28/22 documented, .The patient was seen today at the request of nursing following a med (medication) error .the patient was given a dose of Depakote meant for another patient by accident. Depakote will be fully processed through the body in 40 hours .Staff to monitor vital signs and watch for side effects for 40 hours .monitor for 40 hours following accidental ingestion of Depakote .
Resident #15 had no physician's order for Depakote. The clinical record did not document the Depakote dosage that was administered in error.
On 4/20/22 at 4:30 p.m., the licensed practical nurse (LPN #1) caring for Resident #15 was interviewed about the medication error. LPN #1 stated she was not aware of the medication error. LPN #1 reviewed the nursing notes and stated the med error was documented by a night shift nurse.
On 4/20/22 at 4:41 p.m., the registered nurse unit manager (RN #1) was interviewed about the Depakote administered to Resident #15. RN #1 stated she was not aware of a medication error involving Resident #15. RN #1 stated, I don't recall knowing that.
This finding was reviewed with the administrator and director of nursing (DON) during a meeting on 4/20/22 at 5:00 p.m. The DON stated at this time that she was not aware Depakote was administered to Resident #15 in error.
The Nursing 2022 Drug Handbook on pages 1492 and 1493 describes Depakote as an anticonvulsant medication used for the treatment of seizures, mania and migraine headaches with possible adverse reactions such as dizziness, drowsiness, insomnia and rash. (1)
b) On 4/19/22 at 2:40 p.m., Resident #15 was interviewed about quality of care in the facility. Resident #15 stated his right ear had been stopped up with wax for over a week. The resident stated staff told him they were going to order drops and then irrigate the ear to remove the wax. The resident stated he had received no drops as of today (4/19/22). Resident #15 stated he had pressure and was not able to hear well out of the right ear due to the impacted wax. The resident described the condition as aggravating. Resident #15 stated he had reported to nurses and the nurse practitioner that he had not received drops and nothing had been done to relieve the ear wax.
A nurse practitioner (NP) progress note documented the resident was assessed on 4/12/22 for complaints of right ear wax. This progress note documented, .is complaining of right ear feeling plugged and thinks it is wax build up .On otoscopic exam, right TM (tympanic membrane) obscured by cerumen .Impacted cerumen .debox (Debrox), then flush ear in 5 days .
Resident #15's clinical record documented a physician's order dated 4/13/22 for Debrox solution 6.5% with instructions to instill 4 drops in the right ear two times per day for five days for treatment of impacted cerumen. Nursing notes documented a physician's order dated 4/18/22 to flush ear after 5 days of Debrox drops with use of tepid water due to impacted cerumen in the right ear.
Resident #15's medication administration record (MAR) from 4/13/22 through 4/20/22 documented the Debrox solution was not administered because the drops were not available. MAR notes from 4/12/22 through 4/20/22 documented the Debrox was on order from the pharmacy and Not delivered . There was no entry on the MAR regarding the ear irrigation. There was no notification to the provider about the unavailable Debrox.
There were no other treatments and/or interventions implemented for Resident #15's ear wax other than the Debrox that was unavailable. The resident had no plan of care regarding the ear wax or the ear discomfort described by the resident as aggravating.
On 4/20/22 at 10:44 a.m., the licensed practical nurse (LPN) #1 caring for Resident #15 was interviewed about the Debrox. LPN #1 stated the Debrox never arrived from pharmacy. LPN #1 stated messages had been sent to the pharmacy about the Debrox with no response. LPN #1 stated the pharmacy requested a form last evening (4/19/22) and that was sent as requested but she still did not have the drops. LPN #1 was not aware of any other interventions for the impacted ear wax.
On 4/20/22 at 10:46 a.m., the registered nurse (RN #1) unit manager was interviewed about Resident #15's Debrox. RN #1 stated she was told the Debrox had not been sent from pharmacy. RN #1 stated no other interventions had been initiated about Resident #15's impacted ear wax.
c) Resident #15's clinical record documented a physician's order dated 2/23/22 for the medication lisinopril 10 mg (milligrams) with instructions to give one dose each morning for the treatment of hypertension.
Resident #15's MAR documented the lisinopril was not given on 4/12/22, 4/13/22, 4/16/22, 4/17/22 and 4/18/22 because the medication was not available. The MAR documented the medication was administered on 4/15/22 with nursing notes stating the medication was not available. MAR notes documented the following regarding the availability of the lisinopril.
4/12/22 - Lisinopril .ordered .
4/13/22 - .ordered .still on order .
4/14/22 - .on order .awaiting on arrival from pharmacy .
4/15/22 - .on order .
4/17/22 - .on order .
4/18/22 - .Not in stock and reordered .
On 4/19/22 at 3:15 p.m., LPN #1 caring for Resident #15 was interviewed about the lisinopril availability. LPN #1 stated she did not know why the lisinopril had not been provided. LPN #1 stated there were ongoing issues with getting medications from the pharmacy.
On 4/19/22 at 3:24 p.m., unit manager (RN #1) was interviewed about Resident #15's lisinopril. RN #1 stated medications were ordered from the pharmacy and they just don't show up. RN #1 stated the pharmacy did not communicate when medications were not available. RN #1 stated the pharmacy was supposed to provide a back-up service for needed medications but that protocol had not been effective in getting medications.
On 4/20/22 at 9:42 a.m., the director of nursing (DON) was interviewed about the unavailable medications. The DON stated when medications were out, nurses were supposed to call the pharmacy and request the needed drugs. The DON stated there was an emergency supply of some medications onsite but it did not contain all medications. The DON stated the pharmacy was supposed to provide back-up service for needed medications.
These findings were reviewed with the administrator and director of nursing during a meeting on 4/20/22 at 5:00 p.m.
4. Resident #46 was admitted to the facility with diagnoses that included Parkinson's disease, orthostatic hypotension, hyperlipidemia, seizures, gout, major depressive disorder and dementia with behavioral disturbance. The minimum data set (MDS) dated [DATE] assessed Resident #46 as cognitively intact.
Resident #46's clinical record documented a physician's order dated 4/13/22 for Aricept 10 mg (milligrams) to be administered at each bedtime for dementia. The record documented a physician's order dated 4/13/22 for Remeron Soltab 15 mg to be administered at each bedtime for depression.
Resident #46's medication administration record (MAR) documented the Aricept and Remeron were not administered on 4/18/22 as ordered. A nursing note dated 4/18/22 documented regarding the Aricept and Remeron, medication unavailable.
On 4/20/22 at 9:42 a.m., the director of nursing (DON) was interviewed about unavailable medications. The DON stated when medications were out, nurses were supposed to call the pharmacy and request the needed drugs. The DON stated there was an emergency supply of some medications onsite but it did not contain all medications. The DON stated the pharmacy was supposed to provide back-up service for needed medications.
On 4/20/22 at 3:47 p.m., the registered nurse unit manager (RN #5) was interviewed about the doses of Aricept and Remeron not administered to Resident #46. RN #5 stated the Aricept and Remeron were identified as on order from the pharmacy. RN #5 stated she did not know why these medications ran out and a supply was not maintained.
This finding was reviewed with the administrator and director of nursing during a meeting on 4/20/22 at 5:00 p.m.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Pharmacy Services
(Tag F0755)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 5. Resident #14 was admitted to the facility with diagnoses including chronic pain syndrome, gastro-esophageal reflux disease (G...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 5. Resident #14 was admitted to the facility with diagnoses including chronic pain syndrome, gastro-esophageal reflux disease (GERD), glaucoma, hypo-osmoliaty, hyponatremia, major depressive disorder, anxiety disorder, hypertension, and joint pain (knees and hands). The most recent MDS dated [DATE] was a quarterly assessment and assessed Resident #14 as cognitively intact for daily decision making with a score of 15 out of 15.
Resident #14 was interviewed on 04/19/2020 at 12:11 p.m. Resident #14 stated there had been 3 to 4 days when the scheduled Lidocaine pain patches were not available for administration. Resident #14 stated, I get 3 of the same patches a day on my knees and shoulder because I have joint pain. From my understanding the medications come from a pharmacy in North Carolina and there was a mix-up in getting them delivered here. When asked about his pain level, Resident #14 stated, It was bearable even at my age. But, it just didn't make sense to me that I missed that many days. I get other pain medications so I'm sure that took some of the edge off.
Resident #14's clinical record included the following orders:
Aspercreme Lidocaine 4% Patch. apply to left knee topically in the morning remove at bed time. Start Date: 12/15/2021.
Aspercreme Lidocaine 4% Patch. Apply to left shoulder topically in the morning for pain remove at bedtime. Start Date: 12/09/2021.
Aspercreme Lidocaine 4% Patch. Apply to right knee topically in the morning for pain remove at bedtime. Start Date: 12/09/2021.
Resident #14's medication administration record (MAR) was reviewed and documented on 04/10/2022, 04/11/2022, 04/12/2022, and 04/13/2022, the morning administration of each of the scheduled Aspercreme Lidocaine 4% patch was not administered for the left knee, right knee, and left shoulder. The missed doses were marked as 9, other/see progress notes.
Nursing notes dated 04/10/2022 at 8:28 a.m. documented concerning the medication patches not administered, patch on order. Nursing notes dated 04/11/2022 at 12:16 p.m. documented, Notified NP. Nursing notes dated 04/12/2022 at 8:56 a.m., documented, on order. Nursing notes dated 04/13/2022 at 9:34 a.m. documented, on order. There was no documentation about use of a back-up pharmacy to acquire the medication patches.
On 04/20/2022 at 9:39 a.m. the licensed practical nurse (LPN) #3 who routinely provided care for Resident #14 and documented the nursing notes on 04/10/2022, 04/12/2022, and 04/13/2022 was interviewed about the missed doses. LPN #3 stated, There was some recent confusion about pharmacy changes with the patches switching from the pharmacy order to becoming house stock. We were ordering them from the pharmacy and waiting for them delivery and then we found they were switched to a house stock item. You can speak with the unit manager or DON for more information because there was a meeting to discuss the new house stock items.
On 04/20/2022 at 9:42 a.m., the director of nursing (DON) and assistant director of nursing (ADON/RN #3) were interviewed. The DON stated the facility switched to a new pharmacy on January 1, 2022 and the facility had identified a problem with receiving medications. The DON shared the facility recently met with the pharmacy on Monday, 04/18/2022 and identified the house stock list had changed and the facility was not aware of the change. The DON stated, Told us to pull from our house stock and we weren't aware the list had grown. (Corporate) grew the list and they didn't tell us. The DON was asked if the Lidocaine 4% patches were part of the house stock list. The ADON/RN #3 stated, Yes if it's on the house stock list we provided you all. Then it's house stock, but previously they were ordered through the pharmacy.
On 04/20/2022 at 10:11 a.m. the central supply clerk (OS #1) who was responsible for ordering house stock items was interviewed. OS #1 stated, At first I was given a very short list of house stock items. I order weekly for supplies and over the counter (OTC) and house stock medications. We did just get an updated list and I'm told this is probably not all of the OTC/house stock meds. It will probably change again. OS #1 was asked when were the Lidocaine 4% patches ordered. OS #1 stated, I spoke with (LPN #3) about the situation and they were ordered about 2 weeks ago. We use the Aspercreme or Salonpas 4% generic brands as house stock. I made sure to give her a large bag of them for the med cart.
On 04/20/2022 at 11:34 a.m. the pharmacy representative (OS #5) was interviewed via phone with the survey team. During the phone interview, OS #5 stated, .the facility is responsible for house items not the pharmacy
A review of the (Hill Valley Corporate - Do Not Supply List, Rev. 04/20/2022) documented the Lidocaine 4% as a house stock item.
A review of the facility's policy titled, House-Supplied (Floor Stock) Medications (Rev. 08/2020) documented, When permitted by state regulations, the facility may maintain a supply of commonly used over-the-counter (OTC) medications considered floor stock or house medications (not resident-specific), to be administered only upon receipt of an order from an authorized prescriber
The above findings were reviewed with the administrator, DON, and ADON during a meeting on 04/20/2022 at 4:55 p.m.
Based on staff interview, clinical record review, and facility document review the facility staff failed to ensure medications were available for administration for 5 of 21 residents in the survey sample, Resident #230, Resident #59, Resident #15, Resident #46, and Resident #14.
Findings include:
1. Resident #230 was admitted with diagnoses that included, but were not limited to: BPH (benign prostatic hypertrophy) with urinary retention, indwelling Foley catheter, urinary tract infection, entercolitis, C-Diff (clostridium difficile) infection, PVD (peripheral vascular disease), dementia, high blood pressure and bacteremia (infection in the blood).
The resident's admission MDS (minimum data set) was still in progress. Resident #230's nursing admission assessment dated [DATE] documented, that the resident had dementia with cognitive deficits (unable to answer to place, time and situation).
On 04/20/22 at 11:36 AM, Resident #230 was observed in his room. An IV (intravenous) pole with machine was observed in the corner of the room. Resident #230 was observed with a central line catheter that had a clear, dry dressing intact.
The physician's orders were then reviewed and included the following:
.Aricept tablet 23 mg (milligrams) give one tablet daily in the morning for dementia (order date: 04/15/22) (start date: 04/16/22)
Vancomycin capsule 125 mg give one capsule by mouth four times a day for 8 days for C-diff (order date: 04/15/22) (start date: 04/15/22)
Vancomycin .use 1.75 gram intravenously every 24 hours for C-diff for 7 administrations (order date: 04/15/22) (start date: 04/16/22) .
The MARs/TARs (medication/treatment administration records) were reviewed for the month of April 2022. The MAR documented that Resident #230 did not receive Aricept 23 mg on April 16th, 17th, 18th, or 19th. The resident's progress notes documented that the medication was unavailable, on order, or awaiting from the pharmacy on these days.
The MARs also documented that Resident #230 did not receive oral Vancomycin 125 mg capsules on April 16th (3 doses), April 17th (two doses) and April 19th (one dose). The resident's progress notes documented that the oral Vancomycin was on order from the pharmacy and not available for administration on these days.
The MARs documented that Resident #230 did not receive the IV Vancomycin 1.75 grams IV on April 16th, 17th, 18th, or 19th. The resident's progress notes documented that the IV medication was on order from the pharmacy (04/16/22).
A nursing progress note dated 04/18/22 documented that clarification was needed from the MD (Medical Doctor) regarding this medication. There was no clarification found in the resident's records regarding this medication.
A nursing progress note dated 04/19/22 documented that the IV Vancomycin was on hold related to issues with pharmacy. There was no clarification regarding this, nor were there any physician's orders to hold this medication and no information regarding issues with pharmacy.
On 04/20/22 at 9:45 AM, the DON (director of nursing) and the ADON (assistant director of nursing) were interviewed. They were asked what happens if a medication is not available for the nurses to administer. The DON stated, We notify the physician that meds are not available. They were asked if they had been having issues with medications being unavailable for administration. The ADON stated, In the past, yes. The DON stated, Our nurses are still telling us we have problems getting meds that's why we've been having frequent meetings with pharmacy. The DON and ADON stated that they last met with pharmacy in January and the problem was still current. The DON stated, They (pharmacy) say they will call (if meds aren't available), out of stock or on back order .we really don't know either.
On 04/20/22 at 11:35 AM, the pharmacy director of quality was interviewed regarding the IV Vancomycin being unavailable for Resident #230, since being admitted to the facility. The pharmacy director stated that the IV Vancomycin request was sent to the pharmacy on 04/16/22 and the pharmacist had attached a note that the medication was ordered for C-diff (not a blood infection per the resident's hospital discharge summary) and that the medication had been profiled for that reason. The pharmacy director stated the oral Vancomycin 125 mg order was requested and processed on 04/16/22 and 32 capsules (a supply to administer 4 capsules per day for 8 days-as ordered) were delivered on 04/17/22. The pharmacy director stated that IV Vancomycin is not well absorbed and isn't typically used to treat C-diff. The pharmacy director stated that the Aricept was dispensed on 04/16/22, but not delivered to the facility until 04/19/22, and was unsure why there was a delay in delivery.
On 04/20/22 at 4:45 PM, LPN (Licensed Practical Nurse) #1 was interviewed regarding Resident #230 not being administered the ordered medications. LPN #1 stated that the facility had been having ongoing trouble getting medications from the pharmacy. LPN #1 stated that they do carry some medications in they pyxis machine, but not everything that they may need, and that the facility does have house stock meds.
At 4:50 PM, the unit manager, Registered Nurse (RN) #1 was interviewed regarding Resident #230 not getting medications as ordered by the physician. RN #1 stated that the facility has had trouble getting medications for residents and that the facility has switched pharmacies.
On 04/20/22 at 5:15 PM, the DON (director of nursing), ADON (assistant director of nursing) and the administrator were made aware of concerns regarding Resident #230 not getting medications as ordered by the physician and that according to the pharmacy, some medications were here to be administered, while others required clarification. The DON was asked for a policy on unavailable medications and the pharmacy contract.
A policy titled, Unavailable Medications documented, .Medication used by residents in the nursing facility may be unavailable for dispensing from pharmacy on occasion .due to .out of stock .recall .manufacturer's shortage .medication no longer being produced. The facility must make every effort to ensure that medications are available to meet the needs of each resident .The pharmacy staff shall .notify nursing staff that the order product is/are unavailable .Notify nursing staff of when it is anticipated that the drug(s) will be become available .Suggest alternative, comparable drug(s) and dosage of drug(s) that is/are available .The nursing staff shall .notify the attending physician or on call physician when applicable of the situation and explain the circumstances, expected availability, and alternative therapies available. If the facility nurse is unable to obtain a response from the attending physician or on call physician, the nurse should notify the nursing supervisor and contact the facility director for orders and/or direction .notify the pharmacy of replacement order .
No further information and/or documentation was presented prior to the exit conference on 04/21/22.
2. Resident #59's was admitted with diagnoses that included: Atrial fibrillation, high blood pressure, depression, polyneuropathy, spinal stenosis, chronic back pain, abdominal pain, abdominal pain, hyponatremia, and constipation.
The most current MDS was an admission assessment dated [DATE]. This MDS assessed the resident with a cognitive score of 14, indicating the resident was intact for daily decision making skills.
Resident #59's clinical records documented in the progress notes that several, physician ordered medications for Resident #59 were not available for administration.
The resident's physician orders included the following:
Dulcolax 5 mg tablet every night at bedtime for laxative (order date: 04/09/22/start date: 0409/22)
Bio-Freeze gel 4% topical for left hip pain apply twice daily (order date: 04/13/22/start date: 04/13/22)
Naproxen tablet 220 mg give one tablet twice daily for inflammation (order date: 04/09/22/start date: 04/09/22)
Magnesium Citrate solution 1.745 grams/30 ml (milliliters) Give 30 ml by mouth in the morning for laxative (order date: 04/09/22/start date: 04/10/22)
Sodium Chloride tablet give one tablet by mouth one time a day for hyponatremia (order date: 04/15/22/start date: 04/16/22).
The MARs/TARs (medication/treatment administration records) for the month of April 2022 indicated Resident #59 did not receive the following medications as ordered by the physician:
Dulcolax 5 mg tablet each night for 9 days.
Eleven of 14 doses of Bio-Freeze gel 4%.
Twenty of 22 ordered doses of the twice daily Naproxen 220 mg.
Magnesium Citrate solution for 5 of 11 days.
Sodium Chloride tablet daily for 6 days.
The progress notes documented that all of the above medications were on order, not available and/or awaiting pharmacy on the days the medication was not administered.
On 04/20/22 at 9:45 AM, the DON (director of nursing) and the ADON (assistant director of nursing) were interviewed. They were asked what happens if a medication is not available for the nurses to administer. The DON stated, We notify the physician that meds are not available. They were asked if they had been having issues with medications being unavailable for administration. The ADON stated, In the past, yes. The DON stated, Our nurses are still telling us we have problems getting meds that's why we've been having frequent meetings with pharmacy. The DON and ADON stated that they last met with pharmacy in January and the problem was still current. The DON stated, They (pharmacy) say they will call (if meds aren't available), out of stock or on back order .we really don't know either.
On 04/20/22 at 11:45 AM, the pharmacy director of quality was interviewed regarding medications being unavailable for Resident #59. The pharmacy director of quality stated that the medications Dulcolax, Magnesium Citrate, Naproxen, Bio-Freeze and Sodium Chloride tablets are all house stock medications and are supplied by the facility, not from the pharmacy.
On 04/20/22 at approximately 12:45 PM, the administrator, DON and ADON were made aware of the above information and concern over medications not available for administration. The DON stated that their house stock medications just recently got updated and they were not made aware, but they now have the updated list.
A policy titled, House - Supplied (Floor Sock) Medications documented, .the facility may maintain a supply of commonly used over the counter medications considered floor stock or house medications to be administered only upon receipt of an order from an authorized prescriber .The floor stock medication list is posted in the medication rooms/carts with the facility policy, and provided to the dispensing pharmacy .floor stock medications are ordered from the contracted supplier .
The pharmacy contract was reviewed and documented, .The pharmacy shall deliver medications and provide services to the facility 7 days a week, 365 days a year .The pharmacy shall establish an emergency system for backup and/or interim order dispensing. Any emergency drug supply provided under this section shall be the property of the pharmacy .The pharmacy shall provide the pharmaceutical services in compliance with all applicable laws .Non-Prescription Drugs: The facility may order OTC drugs from the pharmacy and such drugs shall be billed to the facility .
On 04/21/22 at approximately 11:00 AM, the administrator, DON, and ADON were made aware of the concerns with medications not being available for administration.
No further information and/or documentation was provided prior to the exit conference on 04/21/22.3. Resident #15 was admitted to the facility with diagnoses that included bladder-neck obstruction, diabetes, anemia, acute kidney failure, atrial fibrillation, hyperlipidemia, hematuria and hypertension. The minimum data set (MDS) dated [DATE] assessed Resident #15 as cognitively intact.
a) On 4/19/22 at 2:40 p.m., Resident #15 was interviewed about quality of care in the facility. Resident #15 stated his right ear had been stopped up with wax for over a week. The resident stated staff told him they were going to order drops and then irrigate the ear to remove the wax. The resident stated he had received no drops as of today (4/19/22). Resident #15 stated he had pressure and was not able to hear well out of the right ear due to the impacted wax. The resident described the condition as aggravating. Resident #15 stated he had reported to nurses and the nurse practitioner that he had not received drops and nothing had been done to relieve the ear wax.
A nurse practitioner (NP) progress note dated 4/12/22 documented the resident was assessed complaints of right ear wax. This progress note documented, .is complaining of right ear feeling plugged and thinks it is wax build up .On otoscopic exam, right TM (tympanic membrane) obscured by cerumen .Impacted cerumen .debox (Debrox), then flush ear in 5 days .
Resident #15's clinical record documented a physician's order dated 4/13/22 for Debrox solution with instructions to instill 4 drops in the right ear two times per day for 5 days for treatment of impacted cerumen.
Resident #15's medication administration record (MAR) from 4/13/22 through 4/20/22 documented the Debrox solution was not administered because the drops were not available. MAR notes about the unavailable Debrox were as follows.
4/12/22 - Debrox Solution .On order .
4/13/22 - .still on order .
4/14/22 - .on order .awaiting arrival from pharmacy .
4/15/22 - .on order .
4/16/22 - .Not delivered yet .
4/17/22 - .On order from pharmacy .
4/18/22 - .Not in stock on order .On order from pharmacy .
4/20/22 - .Pharmacy notified the debrox solution did not come last pm as expected .
On 4/20/22 at 10:44 a.m., the licensed practical nurse (LPN) #1 caring for Resident #15 was interviewed about the Debrox. LPN #1 stated the Debrox never arrived from pharmacy. LPN #1 stated messages had been sent to the pharmacy about the Debrox with no response. LPN #1 stated the pharmacy requested a form last evening (4/19/22) and that was sent as requested but she still did not have the drops.
On 4/20/22 at 10:46 a.m., the registered nurse (RN) #1, unit manager, was interviewed about Resident #15's Debrox. RN #1 stated she was told the Debrox was on the list and ordered. RN #1 stated the Debrox had not been sent from pharmacy.
On 4/20/22 at 11:02 a.m., the facility's supply clerk (other staff #1) was interviewed about the Debrox. The supply clerk stated the list of house stock items was recently updated with about 100 meds (medications). The supply clerk stated no Debrox had been ordered for the facility.
On 4/20/22 at 11:34 a.m., the registered pharmacist/director of quality (Rph - other staff #5) was interviewed by phone about Resident #15's unavailable Debrox. The Rph stated the Debrox was a house stock item and was supposed to be ordered by the facility and not supplied by the pharmacy.
b) Resident #15's clinical record documented a physician's order dated 2/23/22 for the medication lisinopril 10 mg (milligrams) with instructions to give one each morning for the treatment of hypertension.
Resident #15's MAR documented the lisinopril was not given on 4/12/22, 4/13/22, 4/16/22, 4/17/22 and 4/18/22 because the medication was not available. The MAR documented the medication was administered on 4/15/22 with nursing notes stating the medication was not available. MAR notes documented the following regarding the availability of the lisinopril.
4/12/22 - Lisinopril .ordered .
4/13/22 - .ordered .still on order .
4/14/22 - .on order .awaiting on arrival from pharmacy .
4/15/22 - .on order .
4/17/22 - .on order .
4/18/22 - .Not in stock and reordered .
On 4/19/22 at 3:15 p.m., LPN #1 caring for Resident #15 was interviewed about the lisinopril availability. LPN #1 stated she did not know why the lisinopril had not been provided. LPN #1 stated there had been ongoing issues with getting medications from the pharmacy.
On 4/19/22 at 3:24 p.m., the unit manager (RN #1) was interviewed about Resident #15's lisinopril. RN #1 stated medications were ordered from the pharmacy and they just don't show up. RN #1 stated the pharmacy did not communicate when medications were not available. RN #1 stated the pharmacy was supposed to provide a back-up service for needed medications but that protocol had not been effective in getting medications.
On 4/20/22 at 9:42 a.m., the director of nursing (DON) was interviewed about the unavailable medications. The DON stated when medications were out, nurses were supposed to call the pharmacy and request the needed drugs. The DON stated there was an emergency supply of some medications onsite but it did not contain all medications. The DON stated the pharmacy was supposed to provide back-up service for needed medications.
On 4/20/22 at 11:34 a.m., the Rph/director of quality (other staff #5) was interviewed about Resident #15's unavailable lisinopril. The Rph stated she would investigate and advise. There was no response from Rph prior to end of the survey on 4/21/22.
These findings were reviewed with the administrator and director of nursing during a meeting on 4/20/22 at 5:00 p.m.
4. Resident #46 was admitted to the facility with diagnoses that included Parkinson's disease, orthostatic hypotension, hyperlipidemia, seizures, gout, major depressive disorder and dementia with behavioral disturbance. The minimum data set (MDS) dated [DATE] assessed Resident #46 as cognitively intact.
Resident #46's clinical record documented a physician's order dated 4/13/22 for Aricept 10 mg (milligrams) to be administered at each bedtime for dementia. The record documented a physician's order dated 4/13/22 for Remeron Soltab 15 mg to be administered at each bedtime for depression.
Resident #46's medication administration record (MAR) documented the Aricept and Remeron were not administered on 4/18/22 as ordered. A nursing note dated 4/18/22 documented regarding the Aricept and Remeron, medication unavailable.
On 4/20/22 at 9:42 a.m., the director of nursing (DON) was interviewed about unavailable medications. The DON stated when medications were out, nurses were supposed to call the pharmacy and request the needed drugs. The DON stated there was an emergency supply of some medications onsite but it did not contain all medications. The DON stated the pharmacy was supposed to provide back-up service for needed medications.
On 4/20/22 at 3:47 p.m., the registered nurse unit manager (RN #5) was interviewed about the unavailable medications. RN #5 stated the Aricept and Remeron were identified as on order from the pharmacy. RN #5 stated she did not know why these medications ran out and a supply was not maintained.
This finding was reviewed with the administrator and director of nursing during a meeting on 4/20/22 at 5:00 p.m.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0760
(Tag F0760)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on staff interview and clinical record review the facility staff failed to ensure two of 21 residents in the survey sample...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on staff interview and clinical record review the facility staff failed to ensure two of 21 residents in the survey sample were free of a significant medication error, Resident #230 and #59. Resident #230 was not administered IV (intravenous) antibiotics for a blood infection for four consecutive days; and Resident #59 was not administered sodium chloride for hyponatremia for 5 days and wasn't administered a bowel regimen, Dulcolax for 9 days.
Findings include:
1. Resident #230 was admitted with diagnoses that included, but were not limited to: BPH (benign prostatic hypertrophy) with urinary retention, indwelling Foley catheter, urinary tract infection, entercolitis, C-Diff (clostridium difficile) infection, PVD (peripheral vascular disease), dementia, high blood pressure and bacteremia (infection in the blood).
The resident's admission MDS (minimum data set) was still in progress. Resident #230's nursing admission assessment dated [DATE] documented, that the resident had dementia with cognitive deficits (unable to answer to place, time and situation).
On 04/20/22 at 11:36 AM, Resident #230 was observed in his room. An IV (intravenous) pole with machine was observed in the corner of the room. Resident #230 was observed with a central line catheter that had a clear, dry dressing intact.
The physician's orders were reviewed and included, Vancomycin .use 1.75 gram intravenously every 24 hours for C-diff for 7 administrations (order date: 04/15/22) (start date: 04/16/22) .
The MARs/TARs (medication/treatment administration records) were reviewed for the month of April 2022. The MARs documented that Resident #230 did not receive the IV Vancomycin 1.75 grams IV on April 16th, 17th, 18th, or 19th. The resident's progress notes documented that the IV medication was on order from the pharmacy (04/16/22).
A nursing progress note dated 04/19/22 documented that the IV Vancomycin was on hold related to issues with the pharmacy. There were no physician's orders to hold this medication and there was no further information regarding issues with pharmacy. There was no evidence that the resident's physician had been notified that the resident was not administered this medication for 4 days.
On 04/20/22 at 9:45 AM, the DON (director of nursing) and the ADON (assistant director of nursing) were interviewed. They were asked what happens if a medication is not available for the nurses to administer. The DON stated, We notify the physician that meds are not available. They were asked if they had been having issues with medications being unavailable for administration. The ADON stated, In the past, yes. The DON stated, Our nurses are still telling us we have problems getting meds that's why we've been having frequent meetings with pharmacy. The DON and ADON stated that they last met with pharmacy in January and the problem was still current. The DON stated, They (pharmacy) say they will call (if meds aren't available), out of stock or on back order .we really don't know either. The DON and ADON were made aware that the resident missed this medication 4 days in a row.
On 04/20/22 at 11:35 AM, the pharmacy director of quality was interviewed regarding the IV Vancomycin being unavailable for Resident #230, since being admitted to the facility (4 days). The pharmacy director stated that the IV Vancomycin request was sent to the pharmacy on 04/16/22 and the pharmacist had attached a note that the medication was ordered for C-diff and that the medication had been profiled for that reason. The pharmacy director stated that IV Vancomycin is not well absorbed and isn't typically used to treat C-diff.
On 04/20/22 at 4:45 PM, LPN (Licensed Practical Nurse) #1 was interviewed regarding Resident #230 not being administered the ordered medications. LPN #1 stated that the facility had been having ongoing trouble getting medications from the pharmacy. LPN #1 was asked if she had notified the physician that Resident #230 was not getting the IV Vancomycin. LPN #1 stated that she had contacted the pharmacy, but had not contacted the physician.
At 4:50 PM, the unit manager, Registered Nurse (RN) #1 was interviewed regarding Resident #230 not getting medications as ordered by the physician. RN #1 stated that the facility has had trouble getting medications for residents and that the facility has switched pharmacies. RN #1 was asked if she had notified the physician that the resident wasn't getting the ordered IV antibiotics. RN #1 stated that she had not notified the physician and also stated that she had contacted pharmacy.
On 04/20/22 at 5:15 PM, the DON (director of nursing), ADON (assistant director of nursing) and the administrator were made aware of the significant concerns regarding Resident #230 not getting IV antibiotics for 4 days.
On 04/21/22 at 8:25 AM, the NP (nurse practitioner) was interviewed regarding Resident #230 not getting the prescribed IV antibiotics for, 4 days straight. The NP stated that she was not aware that Resident #230 had not receive this medication until this morning (04/21/22). The NP stated that the potential negative outcomes from missing the 4 doses of IV antibiotics could result in the resident not going to get better, can be life threatening; the infection would progress, medication may not work as well and prolonged treatment.
No further information and/or documentation was presented prior to the exit conference on 04/21/22.
2. Resident #59's was admitted with diagnoses that included: Atrial fibrillation, high blood pressure, depression, polyneuropathy, spinal stenosis, chronic back pain, abdominal pain, abdominal pain, hyponatremia, and constipation.
The most current MDS was an admission assessment dated [DATE]. This MDS assessed the resident with a cognitive score of 14, indicating the resident was intact for daily decision making skills.
Resident #59's clinical records documented in the progress notes that several, physician ordered medications for Resident #59 were not available for administration.
A hospital Discharge summary dated [DATE] was reviewed. The discharge summary documented that Resident #59 had a 6 day hospitalization from 04/03/22 to 04/09/22. The discharge summary documented that the resident had, nausea and vomiting, abdominal pain, constipation, hypo-osmolality and hyponatremia .resident's symptoms were felt to be related to colonic fecal impaction and was put on a clear liquid diet and aggressive bowel program .hyponatremic .monitor patient's sodium level .Orders: bisacodyl (Dulcolax) 5 mg one tab daily .
The resident's physician orders included the following:
Dulcolax 5 mg tablet every night at bedtime for laxative (order date: 04/09/22/start date: 0409/22)
Sodium Chloride tablet give one tablet by mouth one time a day for hyponatremia (order date: 04/15/22/start date: 04/16/22).
The MARs/TARs (medication/treatment administration records) for the month of April 2022 indicated Resident #59 did not receive the following medications as ordered by the physician: Dulcolax 5 mg tablet each night for 9 days, and Sodium Chloride tablet daily for 6 days.
The progress notes documented that all of the above medications were on order, not available and/or awaiting pharmacy on the days the medication was not administered.
The current care plan was reviewed and documented, diet as ordered .supplements as ordered .document consumption resident has constipation follow facility bowel protocol for bowel management .increase fiber and fluid intake .monitor medications for side effects of constipation .keep physician informed of any problems .
On 04/20/22 at 9:45 AM, the DON (director of nursing) and the ADON (assistant director of nursing) were interviewed. They were asked what happens if a medication is not available for the nurses to administer. The DON stated, We notify the physician that meds are not available. They were asked if they had been having issues with medications being unavailable for administration. The ADON stated, In the past, yes. The DON stated, Our nurses are still telling us we have problems getting meds that's why we've been having frequent meetings with pharmacy. The DON and ADON stated that they last met with pharmacy in January and the problem was still current. The DON stated, They (pharmacy) say they will call (if meds aren't available), out of stock or on back order .we really don't know either.
On 04/20/22 at approximately 12:45 PM, the administrator, DON and ADON were made aware of the above information and concern over medications not available for administration.
On 04/20/22 at 4:45 PM, LPN (Licensed Practical Nurse) #1 was interviewed regarding Resident #59 not being administered the above medications. LPN #1 stated that the facility had been having ongoing trouble getting medications from the pharmacy. LPN #1 stated that they do carry some medications in they pyxis machine, but not everything that they may need and the facility does have house stock meds, but they don't always have all of those. LPN #1 stated that she had not reported to the physician that the resident's medications were not available to administer or that the resident had not received the medications.
At 4:50 PM, the unit manager, Registered Nurse (RN) #1 was interviewed regarding Resident #230 not getting medications as ordered by the physician. RN #1 stated that the facility has had trouble getting medications for residents and that the facility has switched pharmacies. RN #1 stated that she had not reported to the physician that medication was not available to administer or that Resident #59 had not received the medications. RN #1 stated, I did tell the NP in passing about the Sodium Chloride. RN #1 stated that she did document that and did not get any new orders regarding that medication.
On 04/21/22 at 8:25 AM, the NP (nurse practitioner) was interviewed regarding Resident #59 not receiving these medications for days and the significant concerns related to the resident's diagnoses. The NP stated, I didn't know the medications weren't available or that she didn't get them. The NP stated, I did know of a history of colonic impaction (forResident #59), but didn't know she didn't have or receive the bowel medications. The NP was asked about any negative outcomes related to Resident #59 not getting these medications. The NP stated, She could get a bowel obstruction, impaction, ileous and without sodium shloride, she (Resident #59) could have a really bad day, she could end up in the ICU (intensive care unit).
On 04/21/22 at approximately 11:00 AM, the administrator, DON, and ADON were made aware of the concerns with medications not being available for administration and the significant medication error related to multiple missed doses of the above medications.
On 04/21/22 at 11:30 AM, Resident #59 was interviewed. Resident #59stated that she doesn't have a bowel movement every day and it can be uncomfortable. Resident #59 stated that she had a smidge of a bowel movement the day before, but it had been several days or longer that she could say she had a good bowel movement. Resident #59 stated that she wasn't getting the Dulcolax tablets and that staff had been trying to give her Miralax, but that made her sick and nauseated. Resident #59 stated that she had told them that, but they keep trying to give that to her instead of something else. Resident #59 stated that she didn't understand why they would just give her salt to add to her food for the hyponatremia and give her milk of magnesia bowels, and that would be easier and has worked in the past. Resident #59 was asked if she felt constipated. Resident #59 stated that she didn't, but stated that she didn't feel constipated the last time either.
No further information and/or documentation was provided prior to the exit conference on 04/21/22.
CONCERN
(F)
Potential for Harm - no one hurt, but risky conditions existed
Menu Adequacy
(Tag F0803)
Could have caused harm · This affected most or all residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on staff interview, resident interviews, and facility document review, the facility staff failed to offer alternate menu e...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on staff interview, resident interviews, and facility document review, the facility staff failed to offer alternate menu entrée items that were prepared in advance and compatible to other menu items. No meal alternatives menu entrée items were listed on the main menus posted on each unit, or on the copy provided to the residents. The census was 79 residents.
The findings include:
On 04/19/2022 during the initial tour, three3 residents, Resident #8, Resident #35, and Resident #14 stated they were not offered alternate menu items.
Resident #8 was admitted with diagnoses that included, pneumonia, sepsis, chronic kidney disease, and
major depression. The most recent minimum data set (MDS) dated [DATE] was a quarterly assessment and assessed Resident #9 as moderately impaired for daily decision making with a cognitive score of 11 out of 15.
On 04/19/22 at 11:00 a.m. when asked about food and choices Resident #8 stated the food was not very appealing and they did not get a choice or alternative.
Resident #35 was admitted to the facility with diagnoses that included anxiety disorder, cirrhosis of the liver, hepatic failure, congestive heart failure, stage 3 kidney disease, type 2 diabetes, hyperlipidemia, and encounter for palliative care (hospice). The most recent minimum data set (MDS) dated [DATE] was a quarterly and assessed Resident #35 as moderately impaired for daily decision making with a cognitive score of 11 out of 15.
Resident #35 was interviewed on 04/19/2022 at 11:30 a.m. regarding the quality of care and quality of life since being at the facility. Resident #35 stated, I've been here for almost six years and this is home for me. Everyone treats me nice, they answer the call bells and we have so many activities. My only issue is the food. Resident #35 stated, Since the ownership has changed so has the quality of food. We no longer are able to choose the main meal entrée. We have to eat what they serve us. My family brings me food, but I don't feel like that should be the answer. Resident #35 was asked if the facility provided alternate menu items. Resident #35 pulled out a document titled Always Offered Items which included items available for each meal (breakfast, lunch, dinner). Resident #35 stated, We're having fish today and I don't like fish. I've asked for soup which is listed as 'always available' but was told there is no soup. So then I asked for a grilled cheese. I will have to wait to eat with my roommate. We've talked with the dietary manager (OS #2) so many times and just seems like nothing is getting done. Resident #35 stated, Look at the menu they give us. Some of these food names I don't even know what they are. Then we have to match up the calendar dates at the top of with the menu week number to figure out what we're having for each meal. It's very confusing. We've asked them to change the menus so they are easily understood and to allow us to check what we want to eat.
A review of Resident #35's lunch meal ticket documented low sodium, no concentrated sweet diet and the following items for lunch: herb and lemon fish (3 ounces), mashed garlic cauliflower (1/2 cup), squash medley (1/2 cup), assorted ice cream (1/2 cup), diet lemonade (8 fl oz). 2 sweet n low/ 1 pepper.
Resident #14 was admitted to the facility with diagnoses including chronic pain syndrome, gastro-esophageal reflux disease (GERD), glaucoma, hypo-osmoliaty, hyponatremia, major depressive disorder, anxiety disorder, hypertension, and joint pain (knees and hands). The most recent MDS dated [DATE] was a quarterly assessment and assessed Resident #14 as cognitively intact for daily decision making with a score of 15 out of 15.
Resident #14 was interviewed on 04/19/2022 at 12:11 p.m. regarding the quality of care and quality of life since being admitted to the facility. Resident #14 stated, The food is horrible. You don't get to choose your own meal or select what you want to eat anymore since we have new owners. We had a meeting with the Ombudsman to discuss food concerns. Resident #14's lunch meal tray was observed on the tray table. Resident #14 pointed toward the meal tray and stated, Just look at this mess. Who wants this fish, it's not our usual fish. We used to have flounder or tilapia. I have no idea what this it. Then who in their right mind wants mashed cauliflower and these squash looked barely cooked. Resident #14 was asked if alternate menu items were provided. Resident #14 stated, No ma'am. Before we were sold out, we received a menu where we could check off what we wanted. Now if you don't like what is served, you either suck it up and eat it, go hungry or have someone to bring you something from home or a restaurant. I'm paying good money to be here and so is my insurance provider. We expect to have good care and good food.
On 04/19/2022 at 12:12 pm., the facility's administrator stated Resident #14 had meet with the Ombudsman earlier this month to discuss food concerns. The administrator stated the residents had developed a dining committee to address their concerns with dietary and the dietary manager was addressing the concerns as he was notified of them.
A review of the Resident Council Meeting minutes for the months of November 2021 through April 2022 documented the following dietary concerns:
November 1, 2021 .(Dietary Manager and Clincial Dietitian) were in attendance to answer questions, complaints or concerns the resident's might have concerning meals, menus, etc .Residents were happy to be informed of a new dietary meal selections .
December 7, 2021 .(Dietary Manager) addressed resident's concerns during the meeting. Residents should feel fee to have staff call the kitchen when something is not right with their meal. Dietary continues to work on all issues brought to their attention as they come in. Dietary meets with residents that have concerns on a day by day basis to change meal settings to what they prefer Residents shared their thoughts about the meals now being provided. The Thanksgiving meal was good. Some stated the meat was sometimes not done/too done and at time too tough. Preferred a different brand of sausage .
January 4, 2022 .Residents had some concerns of dietary and dietary staff follow-up on those concerns.
February 1, 2022 .residents had concerns about dietary and asked to have a separate meeting about the food selection .We have scheduled a food committee meeting on March 2, 2022 .
The March 2022 group meeting was canceled due to COVID related concerns.
A review of the Resident Dining Committee minutes from April 6, 2022 documented the facility started new menus on April 3. The new menus were reviewed and the dietary manager stated he continues to work on changing the names of some of the menu items to make them more identifiable. The minutes documented the residents' concerns with the process to request a meal/food substitution and how long the process took to receive their requested item. Per the minutes, the ombudsman suggested the residents were provided copies of the updated menu so they could review and send in what they want to substitute.
On 04/19/2022 at 1:00 p.m. a group meeting was conducted with four cognitive intact residents, Resident #8, Resident #35, Resident #14, and Resident #11. Resident #14 stated, We don't have much to look for at our age and food is one of those things that makes most people happy and brings them together. We all understand the facility changed owners, but it has been since November and some things should have gotten better. The group was asked if they were provided with menus and the always offered list. Resident #8 stated, No, I don't know anything about that 'always offered list.' I have the menu list but that is very confusing to read and sometimes they don't serve us the main entrée listed. They tell us the menus may change because items are out of stock or supply change issues.
Observed posted on the wall near the second floor nursing station was the current menu. There were no alternative menu entrées listed for lunch or dinner meals.
On 04/20/2022 at 2:58 p.m. the dietary manager (OS #2) was interviewed regarding the facility offering alternate meal items. OS #2 provided a copy of the always offered item list and stated, We don't have an alternate. When we were with (previous owners) we had an alternate meal option, but when we changed over to the new company it was stopped. We have the one main entrée for lunch and dinner. OS #2 continued and stated, We offer an alternate item next door at AL (assisted living), but not here. OS #2 was asked if the resident's preferences were reviewed and documented. OS #2 stated, Yes when we switched owners I went around to the residents and updated their preferences in the dietary system. Also, we just changed to our new Spring/Summer menus and when I'm told resident's don't like certain foods I continue to update their meal tickets. It has been a process with all of the changes. We recently meet with the dining committee and the ombudsman to discuss more changes. I'm working on updates, but it does take time. OS #2 was asked if the residents were notified when the menu changed due to availability issues. OS #2 stated, I have to get creative sometimes if items are out of stock. I discussed with the residents that I plan to update the menus and if items aren't available I will let them know what the substitutes are.
The above findings were reviewed with the administrator, director of nursing (DON), and assistant director of nursing (ADON) during a meeting on 04/20/2022 at 4:55 p.m.
CONCERN
(F)
Potential for Harm - no one hurt, but risky conditions existed
Infection Control
(Tag F0880)
Could have caused harm · This affected most or all residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, staff interview, facility document review and clinical record review, the facility staff failed to follow ...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, staff interview, facility document review and clinical record review, the facility staff failed to follow infection control protocols for one of twenty-one residents in the survey sample, Resident #75; and failed to implement facility protocols for Legionella prevention.
The findings include:
1. Resident #75 was admitted to the facility with diagnoses that included clostridium difficile (C-diff), sepsis, chronic respiratory failure, hypoxia, COPD (chronic obstructive pulmonary disease), epilepsy, chronic pain, history of venous thrombosis and major depressive disorder. The minimum data set (MDS) dated [DATE] assessed Resident #75 as cognitively intact.
Resident #75's clinical record documented a physician's order dated 3/31/22 for contact precautions due to C-diff colitis.
On 4/20/22 at 8:56 a.m., certified nurses' aide (CNA) #1 was observed entering Resident #75's room. CNA #1 had on a mask but no gown or gloves and performed no hand hygiene prior to entering the room. CNA #1 retrieved the resident's partially eaten meal tray from breakfast, picking up the banana still on the tray. CNA #1 took the tray from the resident's room and placed it on a cart in the hall near the nursing desk. CNA #1 performed no hand hygiene upon exit from the room. CNA #1 then went to a resident eating breakfast in the day area and assisted with her tray items, touching the resident's napkin. Without hand hygiene, CNA #1 went to the nursing desk and used the telephone to call the kitchen for requested food items.
On 4/20/22 at 9:01 a.m., CNA #1 was interviewed about not donning PPE prior to entering Resident #75's room and no hand hygiene after handling her breakfast tray. CNA #1 stated the resident was on contact precautions. CNA #1 stated gloves and a gown were not required unless she was providing direct care for the resident. CNA #1 stated she was not required to put a gown and gloves on/off when picking up food trays from residents on contact precautions.
On 4/20/22 at 2:48 p.m., the registered nurse unit manager (RN #5) was interviewed about required PPE for Resident #75. RN #5 stated gowns and gloves were required for all staff crossing the threshold of Resident #75's doorway. RN #5 stated the resident was on contact precautions due to infection with C-diff. RN #5 stated the gown and gloves were to be discarded prior to exiting the room and hands washed. RN #5 stated CNA #1 should have donned a gown and gloves prior to entering Resident #75's room.
The facility's policy titled Transmission-Based Precautions (undated) documented, The facility will ensure systems and processes are in place for the prevention and spread of infectious diseases .Contact Precautions: may be implemented for residents known or suspected to be infected with microorganisms that can be transmitted by direct contact with the resident or indirect contact with environmental surfaces or resident-care items in the resident's environment . This policy documented concerning protocol for contact precautions, .Staff and visitors will wear gloves when entering the room for all interactions that may involve contact with the resident and/or the resident's environment .Staff and visitors will remove gloves and perform hand hygiene prior to leaving the resident's room .Staff and visitors will wear a gown when entering the room for all interactions that may involve contact with the resident and/or the resident's environment .Staff and visitors will remove the gown and perform hand hygiene prior to leaving the resident's room .
This finding was reviewed with the administrator and director of nursing during a meeting on 4/20/22 at 5:00 p.m.2. As part of the review of the facility's Legionella Protocol, documentation was requested regarding surveillance (testing) of those areas where Legionella and other opportunistic waterborne agents could grow. The Maintenance Director was identified as the person in charge of the Legionella program.
At 8:40 a.m. on 4/21/2022, the Maintenance Director was interviewed regarding the Legionella and the facility's surveillance program. The Maintenance Director provided copies of water analysis performed on four showers and one whirlpool conducted on 5/7/2018. The analysis results noted No Legionella isolated.
The Maintenance Director said testing was conducted in 2019, but he could not find the results of that testing. Asked about more recent testing, the Maintenance Director said no testing has been conducted since 2019 because of COVID.
At 10:20 a.m. on 4/21/2022, during a meeting with the Administrator, Director of Nursing, Assistant Director of Nursing, Legionella surveillance was discussed. According to the Administrator, testing was put on hold due to COVID and not being able to let vendors in the facility.
At 11:10 a.m. on 4/21/2022, the Director of Nursing, who serves as the Infection Preventionist, was interviewed. Asked if she was aware Legionella testing was not being conducted, she said, No.
MINOR
(B)
Minor Issue - procedural, no safety impact
Deficiency F0582
(Tag F0582)
Minor procedural issue · This affected multiple residents
Based on clinical record review, review of Medicare Beneficiary Notices, and staff interview, the facility staff failed to provide the residents with a Medicare notice of non-coverage for three (3) of...
Read full inspector narrative →
Based on clinical record review, review of Medicare Beneficiary Notices, and staff interview, the facility staff failed to provide the residents with a Medicare notice of non-coverage for three (3) of three (3) residents, Residents # 18, 128, and 130. The residents were not provided notices of Medicare Part A non-coverage prior to their last day of Part A service.
The findings were:
A review of Advance Beneficiary Notices (ABN) included a sample of three residents discharged from Medicare Part A service within the last six months.
Resident # 18 received Medicare Part A Skilled Services starting on 9/17/2021. The last day of coverage for Part A Service was 11/5/2021. There was no evidence the resident was provided with a Notice of Medicare Non-coverage. The SNF (Skilled Nursing Facility) Beneficiary Protection Notification Review form carried the notation Could not locate.
Resident # 128 received Medicare Part A Skilled Services starting on 10/13/2021. The last day of coverage for Part A Service was 11/9/2021. There was no evidence the resident was provided with a Notice of Medicare Non-coverage. The SNF Beneficiary Protection Notification Review form carried the notation Could not locate.
Resident # 130 received Medicare Part A Skilled Services starting on 10/14/2021. The last day of coverage for Part A Service was 11/2/2021. There was no evidence the resident was provided with a Notice of Medicare Non-coverage. The SNF Beneficiary Protection Notification Review form carried the notation Could not locate.
At 10:00 a.m. on 4/20/2022, the Business Office Manager, who was identified as the person responsible for maintaining the ABNs was interviewed regarding the missing notices. The Business Office Manager stated the person who previously was responsible for the ABNs was no longer employed. The Business Office Manager stated that she checked all the files in the office, as well as contacted the previous owner of the facility, but was unable to locate any ABNs for the listed residents.
The findings were discussed with the Administrator, Director of Nursing, Assistant Director of Nursing, and the survey team during a meeting at 4:45 p.m. on 4/20/2022.